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Biett, Lallemand (7), Wendt (8), Le Grand (9), Eberle 
and Kopp. Ma jendi e (10) declared his firm belief that 
the cyanuret of gold promotes coagulation of the blood. 
When, therefore, a decided modification in this fluid is 
desired in haemorrhages or in chronic affections, its ad- 
ministration may prove of great benefit. M. Chavannes 
(II) has found the chloride of gold to be a remedy of rare 
virtue when applied externally as a caustic in lupus, 
syphilitic tubercles and ulcers. 
Orfila (12) affirms that the chloride of gold is more active 
than corrosive sublimate, and that when administered in 
doses of 1/20 to 1 /10 gr. it will give rise to more or less 
inflammation of the gastro- intestinal mucous membrane. 
Experiments on dogs go to prove that even when a very small 
amount of this preparation of gold in solution is injected 
into the jugular vein, death will speedily ensue by vomiting 
and suffocation, preceded by a short paroxysmal cough. 
in 1837, Le Grand published observations on 35 cases of cure 
obtained by the use of gold or its preparations in the treat- 
ment of scrofulous diseases of the glands and other soft 
parts. 
Since the proof of the infectious nature of tuberculos- 
is by Villemin in 1865, and the discovery of the tubercle 
bacillus by i -obert Koch in 1880, there have been numerous 
efforts to find a chemo- therapeutic remedy for tuberculosis. 
As is well known there are two great difficulties - the fatty 
or waxy envelope of the tubercle bacillus and the scanty 
blood supply of tuberculous lesions. 
- 2 
Already in 1890, Koch had shown that K Au Cy2 is 
an extremely powerful bactericide to the tubercle bac- 
illus. Subsequently von Hehring showed that the con- 
centration of 1 /1,000,000 of K Au Cy2 was sufficient to 
prevent the growth of the tubercle bacillus in culture 
media, but that in the presence of serum the growth 
preventing concentration was reduced to l/25,Ò00. 
Previous to the introduction of sanocrysin, various 
attempts were made to treat human tuberculosis by the 
injection of gold salts. An account of their preparat- 
ion and a criticism of the results obtained, is to be 
found in Loellgaard, s book on sanocrysin (15) , where he 
advances arguments to explain the failure of K Au Cy2 
etc., to cure human tuberculosis. 
Moellgaard based his researches on the chemo -ther- 
apeutic principles of Ehrlich. He synthetised a gold 
salt with the formula (8203Au) iva2S203, which he called 
sanocrysin, and the first clinical trials with this sub- 
stance were begun by K.Secker in ivovember 1923. 
Moellgaard gives a full account of the physical, 
chemical and bacteriotropic properties of sanocrysin. 
He cites experiments on calves and smaller animals to show 
that sanocrysin injected intravenously in a concentration 
of 1/75,000 to body weight has no injurious effect on the 
healthy animal, but has most remarkable effects on the 
tuberculous organism. he has the following three groups 
of experiments to prove that sanocrysin exerts a direct 
bactericidal effect on the tubercle bacillus. 
(1) Researches into the influence of sanocrysin on the 
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growth of the tubercle bacillus in culture, showing 
that sanocrysin in a concentration of 1 /100,000, in- 
hibits the growth of T.B. bovinus in cultures, without 
killing all the bacilli; in a concentration of 
1 /1,000,000, it has some inhibitory effect. 
(2) Study of the influence of sanocrysin on the mor- 
phology and staining properties of the tubercle bacillus 
in culture, showing that a 1 /10,000 solution of sanocrysin 
injures the acid -fast properties of T.E. bovinus. 
(3) Researches into the ability of sanocrysin to prevent 
artificially infected guinea -pigs from getting generalised 
tuberculosis, which resulted in four out of five treated 
guinea -pigs escaping generalised tuberculosis, whilst the 
five control guinea -pigs contracted generalised tuberculos- 
is. 
Before considering hoellgaard's later experiments on 
tuberculous animals it must be understood that :ioellgaard 
was convinced that he had in sanocrysin a direct bacter- 
icide to the tubercle bacillus. his interpretation of 
the experiments and the theory of sanocrysin therapy that 
he has built up were based on that assumption. At the 
same time he regards these experiments as the strongest 
indirect evidence that sanocrysin destroys tubercle bacilli 
in vivo and liberates their toxins. ivioellgaard believes 
that sanocrysin injected into a tuberculous mammal, may 
cause symptoms in three ways: - 
(1) Tuberculous toxaemia, due to the liberation of endo- 
toxins or destruction of tubercle bacilli; febrile re- 
actions and loss of weight being ascribed to this cause; 
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(2) "Sanocrysin shocks" due to the formation of a 
toxin under the influence of the tuberculin released by 
destruction of tubercle bacilli, and to the failing 
immunity of the animal to this toxin; 
(3) Tuberculin reactions, which may take the form of 
focal reactions in any part of the body which is infected 
with tuberculosis. 
'Bang (17) attacked Moellgaard's whole position, his 
main points being: - 
(1) Sanocrysin, in a concentration of 1J3,2(;Ú, does not 
inhibit the growth of tubercle bacilli in cultures (Dixon 
(18) thinks that this was due to the presence of protein 
in Bang's experiments); 
(2) Sanocrysin in a 1¡ solution is incapable of killing 
tubercle bacilli in eleven days; 
(3) Sanocrysin has no curative power on experimental 
tuberculosis in rabbits; 
(4) iioellgaard's anti -toxic serum cannot be in any way 
specific, for it is incapable of protecting tuberculous 
guinea pigs against genuine tuberculin shock, provoked by 
the injection of the smallest lethal dose of tuberculin. 
irioellgaard (19), in reply to Bang, argues that sanocrysin 
may be a real bactericide in vivo, even if its action is 
variable in vitro; also sanocrysin may fail to cure tub- 
erculosis in rabbits, and still be effective in the treat- 
ment of other mammals. 
Sir A. aright (20) found that sanocrysin dilutions of 
1 in 250 are without effect on tubercle bacilli in blood, 
and ir.oellgaard has admitted, that the nature of culture 
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and medium have an important influence on the inhibitory 
power of sanocrysin (21) , and quotes further experiments; 
"In my first experiments i found the growth preventing 
concentration to be 1 /100,000. The same has been found 
in two Berman Laboratories. But in recent times iaiadsen 
of the Serum institution of the Danish State has found 
rather big variations in the growth preventing concentrat- 
ions. it appears that the lowest growth preventing con- 
centration has been found in the case of a culture taken 
directly from the sputum, and that laboratory cultures 
accustomed to sprout on artificial media seem to be gener- 
ally more resistant-. 
One chapter of moellgaard's book records the results 
of his experiments with sanocrysin on sound animals. 
Reference has been made tc his claim that sanocrysin,in- 
jected intravenously in amounts not exceeding 1 c.gm.to 
each k.g.m. of body weight, has no injurious effects an 
the animals tested. However, the experiments show that 
larger doses tend to produce albuminuria, and in the case 
of the guinea -pig, tubular nephritis. No pathological 
changes were ever observed in the liver, even following 
very large doses. The excretion of sanocrysin, accord- 
ing to Moellgaard, is chiefly by the kidneys. Gold is 
found in the urine of a healthy calf for four to six days 
after the injection of 1 g.m. of sanocrysin and traces 
of gold are present in the faeces twenty -four hours after 
the final injection of sanocrysin (total amount injected 
17.25 g.m. in twelve weeks) showed the following amount 
of gold in the organs analysed:- 
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Kidneys - 0.71 gm. 
Liver - 0.13 gm. 
Lungs - 0.05 gin. 
Small intestine, caecum, 
colon and intestinal 
contents. - traces only 
Gold differs from many other heavy metals in that it is 
excreted mainly by the kidneys, instead of the intestinal 
canal. No doubt L oellgaard was aware of this, but he 
appears to have overlooked two other remarkable facts. 
In 1913, De Witt (31) and others investigated the distrib- 
ution of gold and other metals in animal tissues. 
Gold seems to select the spleen by preference. This 
organ contains four times as much gold in proportion to 
its weight as the liver or kidney - sometime the kidney 
and sometimes the liver conies second in gold concentration. 
About half the gold administered has been recovered from 
urine and faeces, a week after a single injection. Lore 
is excreted by the urine than by the faeces, at least 
after the earlier injection. A considerable amount of 
gold was recovered from the red blood cells, two to four 
hours after an intra- muscular injection; twenty four 
hours later, none was found. The exact distribution of 
sanocrysin in the healthy human body is not known; prob- 
ably it does not differ much from the proportion found 
in the organs of tuberculous persons who have died after 
sanocrysin treatment. 
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Elliott (32) found that sanocrysin was rapidly 
excreted by the kidneys and to a less degree by the 
intestine. Langmead (33) found 4.75% of the total 
gold salt injected, in the liver; there was only one 
hypertrophied kidney which showed tubular nephritis; 
the kidney was not analysed for gold. The patient had 
been treated with sanocrysin and serum; jaundice was 
present nineteen days before death. Elliott (34) 
examined the kidneys and liver of a patient who died 
after receiving 4 gm. of sanocrysin in eleven days, 
with 300 cc. of serum. The kidneys contained 8% of 
the total gold salt injection, the liver contained only 
about 0.12¡ó. 
McCluskey and Eichelberger (35) have studied the 
results of the intravenous injection of sanocrysin on 
normal dogs. There is a full account of the distrib- 
ution of gold in the organs at varying intervals after 
the final injection. Immediately after an injection, 
the great bulk of the gold is recovered from the kidneys. 
Eight days after the disappearance of gold from the 
urine a small amount persists in the kidneys and spleen, 
approximately equal in proportion to the weight of the 
organs. The conclusions of these workers are as follows: 
(1) The percentage of recovery of gold from the urine 
is practically 60% 
(2) Albumin, varying in amounts from a trace to 1.2 
gm. per litre, was observed in all cases. The albumE - 
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uria increased with increased dosage and lasted for 
a period of from four to ten days with subsequent re- 
appearance. 
(3) The intravenous injection of the gold compound 
in the doses used in dogs caused diarrhoea and oliguria 
and seemed to affect the vomiting centres. The vom- 
itus contained much bile but no gold. 
(4) The excretion of urea, chlorides and creatinine 
in the urine was decreased following an intravenous 
injection of sanocrysin. 
(5) Three to five per cent of gold was excreted 
through the intestine during the first week after the 
injection of sanocrysin. 
(6) The intravenous injections of sanocrysin have no 
effect upon body temperature. 
(7) The greatest amount of gold from sanocrysin local- 
ised in the organs at any time does not exceed 32¡ of 
the amount injected. 
(8) Gold appears in the urine thirty minutes after an 
intravenous injection of sanocrysin. 
Clinical trials with sanocrysin were begun in Nov- 
ember 1923, in several Danish Hospitals and Sanatoria 
(22). It appeared early that the drug was useless in 
"surgical" tuberculosis and dangerous in advanced phthist. 
In spite of many disasters, 136 cases of pulmonary tuber- 
culosis had been treated by the latter end of 1924; 21 
of them died as a direct result of treatment and several 
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others died subsequently. The common causes of death 
were hyperpyrexia, shock and cachexia. Dr.Faber, 
Professor of Medicine at Copenhagen University began 
to treat phthisis with sanocrysin in September 1924., 
and quickly discarded the method of administration 
which had been employed up to that time. Two among 
his first patients died, one of hyperpyrexia and one of 
shock. After observing these two cases Prof.Faber 
decided to lengthen the time interval between the doses 
and to begin with very small doses in severe cases. 
In July 1925, he was able to say that he had treated 
32 cases of phthisis in the past six months without a 
fatality, and in many instances with astonishing improve- 
ment (23). His main principles of treatment were as 
follows:- (1) Dosage: 0.5 gm. for the first dose and 
1 gm. for subsequent doses, increasing gradually. 
(2) Interval between doses: three days between the first 
and second doses and five days between the later doses, 
and if a dose caused a reaction, the treatment was to be 
suspended until all signs of reaction disappeared. 
(3) The use of 1 oellgaard1s anti -toxic serum, which in 
itself caused troublesome and confusing reactions was 
limited to severe cases. (This serum was obtained from 
calves which had been 'immunised' by injections of killed 
cultures of tubercle bacilli). 
(4) Extensive cases of febrile phthisis were not to be 
treated. 
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The clinicians, who collaborated in Moellgaardt s 
book, published preliminary results in 1924 (24). 
The number of cases treated was 156 with the following 
results : - 





The preliminary report of the British Ledical 
Research Council covered the immediate results of treat- 
ment in about 30 cases, of whom 22 definitely had tub- 
erculosis of the lungs. Of these 22, 4 died, 4 were 
worse, the condition of 5 was unchanged and 9 showed 
improvement. 
Results published in July 1925, by Faber (25) were 
more promising. 
On January 12th 1926, therevas a discussion on 
sanocrysin at the Royal Society of Leditine. Prof. 
Elliott had treated 11 cases: he believed that sano- 
crysin produced quicker improvement in pulmonary tuber- 
culosis than did any other treatment. 
Prof. Lyle Cummins thought that sanocrysin gave 
rise to definite improvement but that repeated short 
courses would be found to be necessary. 
Prof. F.R. Fraser considered it doubtful whether 
the advantages of the treatment outweighed the dangers. 
Permin (26) has tried sanocrysin in a number of 
desperate cases of advanced phthisis. In the majority 
the treatment had to be abandoned, but he states that 
10 cases were improved, some of them considerably. 
Lehotay (2?) considered that sanocrysin is contra- 
indicated in severe cases where the Pirquet reaction 
is negative, and a very great rate of sedimentation of 
the red blood cells is present. 
Czerny and Oppitz treated 12 cases of tuberculosis 
in young children and infants; 3 children had tubercular 
meningitis, 3 miliary tuberculosis and 6 advanced pul- 
monary tuberculosis. Eleven of the 12 died, and the 
twelfth patient did not improve. These writers con- 
clude that sanocrysin is useless in the tuberculosis Of 
young children. 
Prof. Friedmann (28) of the Virchow Hospital,Berlin, 
and others have treated 54 cases of pulmonary tubercul- 
osis with sanocrysin. Ten were very much improved. 
Various methods of dosage were used: four cases were 
treated with massive dosage by Secker's method, and they 
all died. After this, Secker's method was abandoned 
and small doses, gradually increased were employed 
(0.1 gm., 0.2 gm., 0.3 gm. etc). Prof.Friedmann says 
"We believe that the improvement in many cases was 
more remarkable than any we have obtained by older 
methods of treatment - - fresh exudative cases offer a 
special field for sanocrysin therapy." K.Herius (29) 
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treated nine severe cases. His general opinion of 
the treatment is distinctly favourable, but the necess- 
ity for selection of cases is emphasised. 
Opinions as to dosage began to alter about this 
time. The large doses advocated by Prof.Moeligaard 
and Dr.Secker had been widely used, with short intervals 
between doses. Given the right type of case this 
heroic line of treatment was effective; but the cases 
capable of standing such intensive treatment are rare 
and the results were often alarming and sometimes regret- 
table. There occurred on the one hand, high temper- 
atures, marked albuminuria, extensive morbilliform or 
scarlatiniform eruptions, nausea and vomiting, loss of 
appetite and loss of weight, sometimes followed by a 
rapid and dramatic improvement after the initial course 
of treatment; or, on the other, the patients might show 
a dangerous drop of temperature, "shock "with the signs 
of oedema of the lungs, marked and persistent anorexia, 
or rapid wasting and cachexia, sometimes leading to 
death within a few weeks in cases which had before treat- 
ment seemed destined to a fairly long survival. 
As a result of these severe reactions, smaller 
doses began to be given, with longer intervals between 
doses and avoidance of the anti- tubercular serum, which, 
while said to be effective in "shock" was in itself very 
trying to the patients and quite unnecessary if "shockt7 
could be avoided. 
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S.L. Cummins (39) advocated an initial course of 
0.25 gm. 0.5 gm. 0.75 gm. i gm. i gm. lgm., the doses 
being separated by intervals of about seven days. 
Even during a course of this description it was 
usual to have considerable reactions after the second 
third and fourth doses, albuminuria, rash or sore mouth. 
It was found, however, that given in this manner 
that a tolerance to increasing doses was soon obser- 
vable. 
Moellgaard's original experimental work began also 
to be very closely criticised, and his contention that 
sanocrysin acted as a 'steriliser' of the tubercle 
infected organism was shown by several workers to be 
untenable. 
Sweany and Wasick (40 & 41) repeated oeligaard's 
work on the effect of the tubercle bacillus in vitro. 
Varying concentrations ranging from 1 :1,000 to 1 & 
1,000,000 were made up in 2T glycerinated agar, and 
these tubes were inoculated with a culture that had been 
on artificial medium for years s1 though it was highly 
virulent for guinea pigs. There was a definite black- 
ening of the bacilli in all dilutions up to and includ- 
ing 1- 20,000 that appeared in about 12 days. There was 
complete inhibition up to 1- 200,000 a partial inhib- 
ition up to 1- 500,000, and slight inhibition in 
1- 1,000,000. 
The process was repeated with an old bovine culture 
with identical results, but a more freshly -isolated 
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human strain behaved a little differently. There 
was not the intense blackening and a few colonies 
grew in concentrations as low as 1-20,000, but died 
out after forty days. These results, although slight - 
less 
lyt favourable than those of Moellgaard, may be said to 
coincide with his inhibitive experiments in glycerine - 
bouillon. 
So far, therefore, as artificial medium was con- 
cerned the product was all that could be desired, but 
when the reaction was transported to animal body fluids, 
numerous complicating factors arose. 
Von Behring (42) pointed this out in working with 
gold. cyanide. In artificial medium, gold cyanide in- 
hibited growth in 1- 1,00r,000 dilution, but in serum the 
inhibition decreased to 1- 25,000. Sweany and Wassick 
found, however, that 5 horse serum in a glycerinated 
bouillon did not decrease the inhibitive results, 
because no growth at all was obtained in 1- 1,000,000 
concentration of sanocrysin. Bactericidal experiments 
were next performed by exposing measured quantities of 
tubercle bacilli to varying concentrations of sanocrysin 
in salt solution and serum for periods up to forty eight 
hours. Bacilli exposed to concentrations of 1- 1,000, 
for two hours grew on Petroff's medium almost as well as 
the controls. 
Small doses of bacilli (about 20,000 per c.c) 
exposed for forty-eight hours in a concentration of 
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1- 5,000 sanocrysin in human serum, produced slightly 
less tuberculosis in guinea pigs than the controls. 
The difference though not marked was definite. 
it was next determined whether the bacilli were 
killed with the salt over long periods of exposure 
by injecting into guinea pigs the original bouillon 
cultures after sixty days incubation. it was found 
here, again, that the organisms survived in 1 -2,000 
concentration for this period of time sufficiently to 
produce a typical tuberculosis. The altered organ- 
isms recovered were quite virulent to guinea pigs. 
Various experiments were then performed to det- 
ermine the effect of the salt on the morphology and 
staining of the bacillus. it was found that the black- 
ing of the bacilli was apparently a deposition of the 
gold in the granular portions of the bacilli, and that 
this did not occur in dead bacilli. As the older organ- 
isms have a greater tendency to granule formation, it 
would follow that this form is the one in which the gold 
is deposited most readily. 
The authors conclude that sanocrysin inhibits the 
growth of the tubercle bacillus in vitro, but rapid bac- 
tericidal power is practically nil. The effect appears 
to be to alter the organisms, but not to decrease mat- 
erially their pathogenicity for guinea pigs. 
This evidence, then as will be discussed below, sets 
at naught the theory of "tuberculin shock" that follows 
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the injection in patients. This 'shock effect' is 
more probably due to a poisoning of the endothelium 
(or modified endothelium) as pointed out by huebner (43). 
Jensen (44) also points out that a negative finding 
of tubercle bacilli in sputum of a sanocrysin case does 
not necessarily indicate that bacilli are absent, but 
may be due to the fact that they are decoloris'ed by 
ordinary methods. 
These experiments on the bactericidal powers of sano- 
crysin show then, that Lioellgaard' s original claim that 
the drug actually penetrates tuberculous lesions, which 
are not rendered impenetrable by fibrosis, and kills the 
enclosed tubercle bacilli, can no longer stand. An in- 
teresting experience of Wirz (45) has some bearing also on 
this point. in two cases of haematogenousskin tubercul- 
ides which he treated with intravenous injections of rel- 
ated gold compounds (aurophos and lopion) new skin lesions 
appeared during the course of treatment. 
Lydia rl. De itt (46) experimented with various gold 
cyanides in tuberculous guinea -pigs, and in 1917 reported 
the significant observation that tubercles flourished in 
the liver, spleen, lungs and other tissues even though the 
concentration of gold in these tissues was much more than 
needed to prevent the growth of the tubercle bacillus in 
the test -tube. TO explain the failure of the substance 
to act in vivo she suggested such possibilities as a trans- 
formation of the chemical in the tissues into an inert 
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forr, , protection of the bacilli by peculiarities of 
their own structure or their cellular environment, or 
a tolerance acquired by the bacilli for gold. 
The proponents of sanocrysin explain its alleged 
superiority on the basis of a diffusibility greater than 
that of such salts as the cyanides. Practically speak- 
ing, however, the important point is that there has been 
no conclusive proof of the ability of injected sanocry- 
sin to kill tubercle bacilli in diseased animals and that 
the available evidence is decidedly against such an hypo- 
thesis. 
In human pulmonary cases evidence of considerable 
weight in relation to this allegedly specific effect should 
be obtained from a study of changes in the bacillary con- 
tent of the sputum. Many clinicians have stressed this 
feature, Koch (47) for example, reports that 39 of 78 sano- 
crysin- treated patients lost tubercle bacilli from their 
sputum, while a like change occurred in only 7 of 65 
"control" cases. Many of his treated cases lost their 
bacilli after two to five doses of the drug. This would 
seem to argue strongly for a sterilizing effect, but a 
close examination of Koch's results shows that he depended 
on the microscopical examination of single sputum smears. 
In view of the work of Sweany, jasi ck (40 Cc 41) , Jensen (44) 
and Amberson, McMahon and Pinner (48) this cannot be taken 
to mean that the sputum is free from virulent tubercle 
bacilli. These latter authors in twelve carefully control- 
led cases, with cultural and inoculation methods of examin- 
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ing the sputum, found no evidence whatever that sano- 
crysin had a sterilizing effect on the living human tub- 
erculous organism. 
In the earlier experimental and clinical investig- 
ation of sanocrysin, the tendency was to attribute almost 
all the by- effects of the drug to the liberation from 
killed bacilli of tuberculous toxins into the blood stream. 
The assumption was based largely on the observation that 
the toxic signs present themselves much more promptly and 
severely in tuberculous subjects than in normals. Since 
this time evidence has accumulated to show that a P:ood 
many of these manifestations are not to be explained as 
"tuberculin- effects "; but as the direct symptoms of met- 
allic (gold) poisoning. Nevertheless, there is reason to 
believe the drug actually does in some tuberculous cases 
elicit certain responses which are closely analogous to 
those produced by the introduction of tuberculin. An 
intensely acute inflammatory reaction about pre- existing 
tuberculous foci in the lungs of man and animals treated 
by sanocrysin has been demonstrated by Yoellgaard, and this 
bears every resemblance to the "tuberculin Pneumonia" of 
Virchow. In clinical cases receiving sanocrysin, it is 
easily possible to attribute the rapid break -down and ex- 
cavation of old tuberculous deposits, as well as their 
peripheral spread, to a similar mechanism. Constitution- 
al symptoms, such as fever, also may fit into this picture. 
Since a tuberculin -like effect may, therefore, be an ac- 
tuality and since there is very slender evidence that this 
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could be due to the killing and disintegration of 
tubercle bacilli lodged in existing lesions, a more 
reasonable explanation must be sought. 
Clinical experience with a number of therapeutic 
agents in tuberculosis has shown that many of them have 
in common the property of exerting a nonspecific effect 
analogous to that of tuberculin. . They seem to stimul- 
ate more or less of an inflammatory reaction in and about 
tuberculous foci, which, if not pushed too far, may be 
turned to good account in some cases, as, for instance in 
those already tending towards fibrosis and healing.The 
agents which may act in this way include non -specific 
proteins, actinic rays, X Rays and certain chemicals, 
like hetol. Such effects from the introduction of heavy 
metals are not infreáuently witnessed in the treatment of 
syphilis complicating tuberculosis. Cummins, who thinks 
that sanocrysin works like other heavy metals, recalls that 
von Linden noted similar reactions after the administration 
of copper compounds to tuberculous subjects. 
Petersen and Levinsen (49) and Levinsen, Petersen and 
Milles (50) in a series of fundamental experiments have 
found a rational explanation of the action of this class of 
substance. 
All the therapeutic agents of the "reactive class ", 
tuberculin, sodium aurothiosulphate (sanocrysin), hetol, 
etc., act seemingly in a relatively simple way. They 
first make the tissues more permeable, and later the tiss- 
ues become less permeable for a considerable period of 
time. 
_ 2n _ 
"The focal reaction, whether in the form that is 
obvious clinically or consisting merely of the imper- 
ceptible biologic reactions following the injections of 
minute doses of the agents in question, is a reaction 
that depends on changes in the permeability of the cap- 
illaries about the tuberculous focus ". 
This conception gives us a logical understanding of 
all the observed reactions except those attributable to 
the direct toxic effects of the drug itself. In other 
words, a certain group of sanocrysin induced symptoms, 
such as fever, rapid pulse, lassitude and loss of weight, 
can reasonably be interpreted, at least to some extent, 
as the constitutional effects of circulating tuberculosis 
"toxins" and these may be liberated from existing tuber- 
culous lesions by some action of the drug. A non -spec- 
ific action, resulting in an alteration of capillary per- 
meability about the tuberculous lesions would seem to be 
wholly sufficient to produce such effects. it does not 
appear necessary to assume a specific bacteriotropic 
action, - especially as this is pure assumption, and 
contrary to all the available evidence. 
In the minds of many who have used sanocrysin ther- 
apeutically there is evident uncertainty in distinguish- 
ing its tuberculin -like effect in the tuberculous organism 
from its direct toxicity. ;-loellgaard and his co- workers 
observed that normal subjects experienced little or no 
harm from the introduction of the drug, whereas the tub- 
erculous sometimes suffered serious damage. This 
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difference led them to assume that the liberation 
of toxins from the tuberculous lesions is practically 
the sole cause of all undesirable effects. The char - 
acteristic reactions with fever, vomiting, diarrhoea, 
stomatitis, skin eruptions and albuminuria, and even 
the more serious effects such as myocarditis and pul- 
monary oedema, were ascribed to this mechanism, which, 
in effect, was assumed to be the same as that operating 
in serum sickness. 
While a tuberculin -like effect enters into the pic- 
ture and is readily explainable, as discussed above, it 
seems to be straining the point too far, to accept this 
as the cause of all the trouble. it is true that an 
overdose of tuberculin may cause profound constitutional 
effects but, viewed broadly, these are seldom of the char- 
acter of certain sanocrysin reactions, which are to be 
interpreted rather as signs of metallic poisoning. Skin 
eruptions of the kind or intensity which occur in sano- 
crysin treatment and stomatitis are never seen from over - 
dosage with tuberculin. Gastrointestinal upsets with 
loss of weight are not uncommon, but unlike sanocrysin 
effects, these are not usually so severe as to result in 
acidosis, nor do they persist long after the febrile re- 
action to tuberculin has passed. 
While in most cases under treatment with sanocrysin, 
the skin eruptions, stomatitis,and gastrointestinal 
symptoms develop simultaneously with or following the 
appearance of fever, it seems significant that in some 
cases the rash comes first, whilst in others there may 
be no raised temperature even though these other man- 
ifestations may be severe. If such a syndrome could 
be assumed to result entirely from the tuberculin -like 
effect of sanocrysin, one would certainly expect the 
fever would be much higher and that it would not be 
antedated by a skin eruption. On this assumption the 
syndrome is an incongruity, and a more plausible ex- 
planation is that the gastrointestinal effects, stomat- 
itis and skin eruptions are caused chiefly if not 
entirely by the metallic salt itself. 
Despite these criticisms of Moellgaardfs work, the 
following statement drawn from his experiments has not 
yet been disproved, viz., that "certain animals in- 
oculated. with a known tubercle strain, which acts fat- 
ally on control -animals, can be restored to permanent 
health if sanocrysin is injected into them intravenously 
in a certain dosage, given at the right time." 
Is there then, a clinical effect corresponding to 
the practical experimental effect? 
As pointed out by Gravensen (51), to give sanocrysin 
an honest trial, cases must be chosen which are in a con- 
dition, as nearly as possible, in agreement with that of 
recently infected animals. The cases primarily selected 
must be those who cope for treatment at an early stage, 
during the development of the fresh spreading disease, 
with exudative infiltrations or disseminated nodules or 
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both combined. Working on these lines Gravensen 
treated twenty -six cases and found that they responded 
well to sanocrysin, improving greatly clinically, with 
a similar improvement in physical signs and X Ray 
picture. In all twenty -six cases there was a complete 
disappearance of any X Ray indication of active fresh 
disease. Synchronously tubercle bacilli disappeared 
from the sputum in all cases where it had previously been 
isolated. 
Gravensen concludes that these results approach as 
nearly as possible to a proof that the clinical effect of 
sanocrysin of whatever nature it may be, corresponds to 
that ofioellgaard's experimental work. He extended his 
line of treatment to cases where fresh and later changes 
appeared in the same patient. He concludes that in there 
also the clinical effect answers the experimental in the 
sense that it is on the fresh spreading disease that the 
sanocrysin acts specifically, and in the mixed cases this 
fresh spreading disease could be treated although no app- 
reciable effect could be expected in old fibrous and 
destrúctive changes. 
His principles of treatment are as follows: - 
(1) Sanocrysin is used primarily when the fresh spreading 
disease predominates. if there are further changes in the 
form of cavities, collapse therapy is indicated secondarily. 
(2) Collapse treatment is used primarily when the later 
changes predominate. Sanocrysin is used as a backing up 
for the arrest of the fresh spreading disease in the 
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collapsed lung, and for a fresh extension of the disease 
in the other lunE. 
(3) Sanocrysin and collapse treatment are used synch- 
ronously when it is evident that sanocrysin at its best 
will lead to a process of breaking down (with massive in- 
filtration and caseous pneumonia), or where the phase of 
the disease indicates one kind of treatment for the one 
lung and different treatment for the other lung. 
Brock (52) following the same line of argument in 
America, tried the drug on the almost purely exudative 
type of lesion, seen not infrequently in the negro. he 
obtained disappointing results in his negro cases in com- 
parison with the same type of disease in the white race 
where he describes his results as "remarkable ". This 
writer suggests that Gravensen's view must be modified. 
The actual acuteness of the lesion does not appear to be 
the chief requisite in selecting cases, but a certain 
amount of immunity must also be present. 
The value of sanocrysin in association with collapse 
therapy is also emphasisedby Bernard (53) who gives his 
indications for its use as follows:- 
(1) unilateral cases already treated with artificial 
pneumothorax but in whom there is a recurrence in which a 
second artificial pneumothorax does not work. 
(2) Artificial pneumothorax not completely efficacious 
in cases with large K Ray opacities. 
(3) Artificial pneumothorax successful, but spread of 
disease to the opposite side occurring. 
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(4) Bilateral disease from the beginning, artificial 
pneumo- thorax being induced on the worse side, the drug 
being given to control the contralateral lung. 
(5) Bilateral disease of a severe type, gold being given 
in addition to bilateral pneumothorax treatment. 
(6) In place of artificial pneumothorax when this has 
proved impossible or has been refused. 
He states that 50;ß of his gold treated cases have 
given favourable results. 
Some of the toxic symptoms following the administration 
of sanocrysin have already been referred to, and may be 
summarised here. Burrell (54) sets them out as follows: - 
1. i`ebrile reactions. These may be divided into three 
groups:- 
(a) A sudden rise of temperature, starting generally 
within an hour of the injection, and lasting several hours. 
There is always a feeling of malaise during the reaction, 
and sometimes a rigor. 
(b) A rise of temperature which may start equally 
suddenly, but which may persist for a feu days, is more 
severe than the first type of reaction and is accompanied by 
malaise, headache, and sometimes.vomiting. 
(c) A long febrile reaction which does not begin until 
after the third injection of sanocrysin. The rise is 
gradual and lasts five days or more. it is always accom- 
panied by albuminuria of a slight degree, but with little 
or no malaise. 
2. Albuminuria. 
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A very faint trace of albumin is found fairly commonly. 
There is a greater tendency for albuminuria to occur as 
treatment continues, and this may persist. Clarke (55) 
states that this occurred in all his treated cases numbering 
eighteen. He states that no red blood cells narrcasts were 
found in any case. Amberson, iiellahon and Pinner (48) 
found that following the third and fourth injections of 
sanocrysin all treated cases showed some evidence of renal 
damage. in the majority of patients this consisted in the 
appearance of a few red cells, occacional renal epithelial 
cells and a few granular casts. 6ome of their patients 
showed traces of albumin. This, however, was much less 
regular than the microscopical changes, and was always pre- 
ceded by the appearance of cellular elements. They con- 
sider that a certain amount of renal damage takes place in 
all patients receiving sanocrysin. 
3. Gastrointestinal symptoms. 
Vomiting may occur directly after injection, and may be 
associated with a febrile reaction. 
Looseness of the bowels is not uncommon, and may develop 
into a troublesome diarrhoea. 
Stomatitis and a metallic taste in the mouth may also 
occur. 
4. Aching of the limbs and rheumatic pains in the joints. 
5. Skin rashes. 
These usually take the form of erythematous rashes but 
may vary from a few small erythematous patches to maculo - 
papular (scarlatiniform and morbillif orm) eruptions dis- 
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tributed over the whole body. Severe cases may go on 
to a desquamative dermatitis. 
Hansburg (56) has described so called "chrysiasis ". 
This consists of a characteristic slate -grey discolor- 
ation of the skin in patches where it is exposed to the 
light - that is, chiefly the hands and face - a discolor- 
ation resembling argyria and due to the precipitation of 
gold in the skin. The precipitation is permanent and of 
grave importance to the patient. reddish blonde persons 
are said to be particularly liable. 
conjunctival injection and neuritis have been descr- 
ibed (48). Amberson, mcvahon and ginner (48) also 
describe one patient who developed jaundice under treatment. 
This case ended fatally and was ascribed to metallic poison- 
ing by the authors. 
A considerable number of cases of agranulocytic angina 
have also been described as following sanocrysin therapy 
(57 to 74) . 
Herpes labialis is an occasional symptom. 
The changes in the blood during sanocrysin therapy have 
been studied by Houghton (76). The author considers that 
in a general way the differential count indicates potential 
resistance to the disease, and the sedimentation rate and 
von Bonsdorff count indicate the condition of the patient 
as the result of the disease. It was found that roughly 
patients undergoing treatment fell into two groups accord- 
ing to their immediate reaction to an initial dose of 
sanocrysin (0.1 or 0.25 gin.) 
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Group A. Group B. 
Total leucocytes Increased Decreased 
Total lymphocytes Increased Decreased 
Total monocytes Decreased or Greatly increas- 
ed. 
slightly decr'd. 
Sedimentation rate Decreased Increased 
Cases which ultimately did well tended to fall into 
Group A., whereas these which failed to improve constantly 
fell into Group B. There was evidence that a sufficient per- 
iod of time was not ordinarily allowed to elapse between 
doses, and his results showed that the influence of an in- 
jection is still evident after fourteen days. Equally marked 
changes in the haemogram were produced by doses of 0.1 gm. 
as by doses of 0.5 gm. 
The sedimentation rate showed in certain cases an immed- 
iate but temporary improvement after an injection, this 
being regarded as a good response. The sedimentation rate 
tended to improve with the rest of the haemogram in all sat - 
isfactory cases. Heaf (7?) also found this of value in 
assessing the prognosis of sanocrysin treated patients. 
Houghton also states that sanocrysin rashes were always 
accompanied and in some cases preceded by an eosinophilia. 
On the evidence of the blood changes, small doses (0.1 gm.) 
were found as efficacious as larger doses (0.5 gm.) and the 
writer states his belief that better results can be obtained 
by extending the interval between doses to fourteen days. 
The question of dosage is one upon which divergent 
views are still held. 
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Seeker (78) holds that many of the poor results 
reported are due to faulty - usually too low- dosage. 
All animal experiments have shown the desirability of 
giving from 1.5 to 2.0 cgm. per kilo. of body weight. 
His usual dosage in patients has been 0.5, 0.75, 1.0 gm., 
the last dose being repeated or increased to 1.25 or 
1.5 gm. if the ,weight of the patient warranted it. His 
first two or three doses are given at two -day intervals 
and the others at intervals of four, five or six days. 
Patients with acute pneumonic processes have only 0.25 
or 0.35 gin. at the first injection as they are likely to 
have severe intoxication. If practicable the treatment 
is continued until there is no reaction after doses of 
1.5 or 2 cgm. per kilo. of body weight, and is then follow- 
ed by a sanatorium regime. Secker is convinced that 
better results are obtained by giving large doses which 
cause reactions than small doses which do not cause re- 
actions. The latter method requires a large number of 
injections, of which the early ones are quite useless 
therapeutically and only increase the amount of metal 
stored in the organism. The absence of a reaction is 
considered by Secker to be by no means a desideratum; the 
activation of a focus, especially an old focus, may be of 
the greatest importance to later healing. 
Pask (79) on the other hand states that the dosage 
should be regulated by the reaction of the patient. In 
an undersized person with poor resistance and unsteady 
temperature his initial doses is very small - 0.025 gm. 
and in the average case 0.05 gin. In the absence of 
reactions the dose is gradually increased to 0.75 gin. 
the total amount given being 5 to 6.5 gm. The smaller 
doses are given at intervals of four to five days, and 
larger doses at intervals of seven to ten days. An 
uneventful course takes twelve to fifteen weeks, but some 
of his cases take much longer. He keeps his patients in 
bed for twenty -four hours after each injection. 
Fabri (80) advocates small doses such as those of 
Pask, rising gradually to a maximum of 0.5 gm. 
Mayer (81) treats over 300 patients weekly in Paris 
with gold, most of whom attend the Laennec Hospital as 
out -patients. He varies his technique and dosage accord- 
ing to the state of the patient and the initial result of 
the treatment. In apyrexial cases, after a preliminary 
injection of 0.1 and a week later of 0.15 gm. of 
"Crisalbin" in 5 cc. of distilled water, he gives weekly 
injections of 0.25 gm. for four months. If there have 
been no reactions and the patient is improving, the in- 
jections are continued for another period of four months, 
when the dosage is again reconsidered. if there have been 
reactions, he continues the weekly injections, but as a 
solvent substitutes 10 cc. of a 10% solution of calcium 
gluconate, for 5 cc. of distilled water. If after four 
months the patient has not improved or the disease has 
spread, though without reactions, he increases the dose to 
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0.5 gm. using 10 cc. of the calcium gluconate solution. 
If after four months of this dosage there is still no 
improvement he abandons the treatment. In febrile cases 
he uses calcium gluconate as a solvent and advocates 
0.25 gm. crisalbin for six weeks, and then 0.5 gm. for 
six weeks, and then 0.75 or even 1 groin. if there has been 
no improvement. he continues treatment for many months, 
but when the sputum becomes free of tubercle, the intervals 
between doses may be increased to a fortnight. He summ- 
arizes his results of 404 cases who have been under treat- 
ment for not less than six months as one third not influen- 
ced, one third improved, and one third much improved or 
cured. 
Wurtzen and S jprslev (82) treated 145 cases with small 
doses and found improvement in W. 
Faber (83) compared the results of large and small 
dosage in two groups of cases and obtained better results 
with the latter. 
Mansell (84) after a trial of dosage based on the prin- 
ciples of Seeker, gave this up and now advocates only small 
doses. 
The general consensus of opinion among present day 
clinicians appears tb be that large doses are dangerous and 
that better results are to be obtained by small doses care- 
fully judged according to the clinical condition and toler- 
ance of the individual patients. 
The present day opinion as regards sanocrysin therapy 
may be briefly summed up as follows:- 
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(1) host authors agree that sanocrysin is of value 
(85): some Trench workers (86) consider that the results 
do not justify the risk. 
(2) Complications appear to be definitely more frequent 
and more severe with large doses than with smaller. 
(3) The exudative type, provided it is not too acute or 
too extensive gives the most successful results, although 
the Japanese specially favour the proliferative type (87). 
(4) Very advanced cases or those with poor resistance are 
made worse. 
(5) Chronic_ fibroid cases show temporary benefit but acute 
exacerbations of chronic disease respond favourably. 
(6) The most constant results are the diminution in amount 
of sputum and its bacillary :content; the majority of cases 
appear to become sputum positive again, however. Changes 
in the physical signs are less constant. 
('7) X Ray improvement has been noted by many workers. 
(8) Roughly 50¡ß of all cases have shown some degree of 
improvement. 
(9) Sanocrysin is shown to great advantage as an adjuvant 
to artificial pneumothorax both for the collapsed and for 
the contralateral lung. 
(10) The results of collapse therapy are far superior to 
those of sanocrysin, in virulent disease, but sanocrysin 
may make an artificial pneumothorax possible in bilateral 
disease, where otherwise it would be precluded by the nature 
and extent of the contralateral disease. 
S U M M A R Y 
of 24. Cases of Pulmonary Tuberculosis 
Treated by Gold Therapy. 
The following twenty -four cases were all admitted 
to Holly Lane Sanatorium, Smethwick, during the year 1934. 
They had all been seen and examined previously, either at 
the tuberculosis dispensary or at their homes. 
Holly Lane Sanatorium admits only early or relatively 
early cases and a large proportion of the patients 
admitted have some form of collapse therapy, this being 
utilised as widely as possible. Gold treatment has been 
used during the past two years but only where collapse 
therapy could not be instituted, or in association with 
collapse therapy under special circumstances, such as 
spread of the disease to the uncollapsed lung. Thus the 
first seven cases were all treated primarily by artificial 
pneumothorax, but all had either at the commencement of 
treatment or at a later date some spread of disease to the 
contralateral lung. 
Cases chosen apart from this group were,as far as 
possible,those who came for treatment at a relatively 
early stage during the development of the fresh spreading 
disease with exudative infiltrations or disseminated 
nodules or both combined. This is the class of case which 
Gravensen (93) and others have shown to be the most 
suitable for this form of treatment, and which conforms 
most closely with Moellgaard's experimental work (15). 
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Cases 8 to 20 form this group in the present series. 
In selecting this group, the greatest care was taken 
to include only cases of such extent of the disease 
that there was no possible doubt as to the diagnosis 
and in fact, all these cases, with only one exception, 
had positive sputa. The one exception (Case 16) never 
had any sputum whilst under observation, but the other 
findings left no doubt as to the diagnosis. No case 
was rejected on account of great extent, other conditions 
being suitable. 
The third and last group, comprising cases 21 to 24 
were more chronic in nature, with fibrous lesions 
predominating, but each of these cases had had a recent 
spread of the disease and it was here, more an attempt 
to check an exacerbation in the course of a chronic 
disease rather than an effort to obtain a "cure ". 
The dosage chosen has been that of small, frequently 
repeated doses regulated by the size and clinical 
condition of the patient as advocated by Pask (79), and 
the procedure has been based largely on the work of 
Mayer (81) . 
The salt used has been "Crisalbin" and the initial 
dose in each case 0.025 gm. di ssolved in 5 c. c. of 
distilled water intravenously. This dose was increased 
_35_ 
to 0.05 gm. , 0.1 gm., 0.15 gm. , and ultimately to 0.25 gm., 
in the first course, if there were no reactions, doses 
being given at three day intervals. A total of from 
5 to 6 gm., was aimed at for one course, this usually 
taking about fourteen weeks. If any reactions ensued 
a rest from tre -tment was given, and when treatment was 
recommenced 10 c.c. of Calcium Gluconate was substituted 
for 5 c.c. of distilled water. In all febrile cases 
also, Calcium Gluconate was used as the solvent. 
If after the first course the patient had not 
improved, or the disease had spread, though without 
reactions, the dose in the second course, which was 
begun after a rest of about two months, was increased 
to 0.5 gm, 0.75, or even 1.0 gm. 
During their first course at least, all patients 
were completely at rest in bed. During subsequent courses 
they might be ambulant in the sanatorium if their 
condition warranted it, or after discharge, attending as 
out patients at the tuberculosis dispensary. 
On admission, in addition to a clinical and 
radiological examination, all Patients had a white blood 
count, a differential count, and a red cell sedimentation 
rate test, performed. The urine was examined chemically 
and microscopically and this was repeated weekly in all 
cases undergoing gold treatment. 
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Blood counts and sedimentation rates were performed 
monthly. Radiograms were repeated regularly at several 
months interval throughout treatment, or more frequently 
if thought necessary. 
The sputum was examined on admission, and all 
positive cases were repeated monthly. Where a sputum 
was negative to commence with or became negative during 
the course of treatment, microscopical examinations 
were repeated thrice weekly. Every patient's sputum 
was measured twice weekly. 
Blood sedimentation rate tests were made according 
to the technique described by Thstergren (105), the 
fall in millimetres being read at the end of the first 
hour. 
When attending as out patients at the dispensary, 
the urine was examined as above at weekly intervals 
in addition to the usual temperature, pulse rate and 
clinical records. Sputum tests were performed monthly. 
All these patients have now been under close 
observation in sanatorium and at the tuberculosis 
dispensary throughout a period of two years, so it is 
felt that a good indication of the value of the treat- 
ment in these cases may now be had from a study of the 
results to date. 
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CASE No. 1. 
Male, aged 22 years. Admitted 7. 6. 34+. 
History: Two attacks of right sided pleurisy since 
December of previous year. Lassitude for several months, 
and recently a cough and sputum. 
Physical signs: Dullness over right upper lobe with 
bronchial breathing below the clavicle and post tussic 
crepitations. Some dullness at left apex with a few 
fine crackles. 
X -Ray: Infiltration at right upper lobe with cavity 
formation; adhesions at right base to diaphragm; increase 
in striae with mottling in left upper lobe. 
General condition poor. Weight 8 st. 13 lbs. 
Sputum - positive. Temperature 98.2 ° - 99 °F. 





An artificial pneumothorax was attempted on 21. 6. 34. 
and a collapse of the upper lobe obtained. A phrenicectomy 
was performed on 2. 8. 34, and a much better collapse of 
the whole lung obtained. 
Crisalbin was commenced on 17. 8. 34.. Dosage: 0.025 gm. 
0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three day intervals. 
0.25 gm. was continued until 27. 11. 34. Total 6. 275 gm. 
Patient's weight had now increased to 9 st. 7 lbs., and 
the sputum was negative. Temperature was normal and the 
patient was feeling extremely well. 
Discharged 22. 12. 34. 
Weight 9 st. 9 lbs. A good collapse of the right lung 
was present, and no moisture was now audible at left apex. 
Slight cough but no sputum. 





CASE No. 1.- (Cont.) 
A second course of Crisalbin from 2. 2. 35. to 18. 5. 35. 
was given with dosage _similar to course one, total 6.275 gm. 
Weight now 9 st. 13 lbs., no cough or sputum. Work as 
a "lorryman's mate" was commenced on 23. 5. 35. and the 
patient has been working since. 
On 20. 6. 36. the weight had increased to 10 st. 10 lbs. 
Artificial pneumothorax treatment was still being carried 
out on the right side and there was no clinical evidence of 
any active disease of the left side. No cough and no 
sputum. The X -Ray showed some fibrosis at the left apex 
but otherwise no evidence of active disease in the left lung. 
16. 8. 34. 20. 6. 36. 
CASE No. 2. 
Female, aged 17 years. 
History of tubercular axillary glands on left side 
at age of twelve; treated conservatively. For two 
months, lassitude and loss of weight; cough for two 
days, no sputum. 
Physical signs: Slight impairment of percussion over 
middle lobe; breath sounds vesicular, no accompaniments. 
X -Ray: Fine tubercular mottling throughout middle 
lobe. 
Admitted 17. 7. 34. '''eight 6 st. 8 lbs. Ueneral 
condition poor. Temperature 100.5 °F. evenings, 98 °F. 
mornings. 





Crisalbin started 6. 8. 34. Dosage: 0.025 gm. 0.025, 
0.025, 0.05, 0.05, 0. 1, 0. 1, 0. 1, 0.15, 0. 15, gm. at three 
day intervals. 
The temperature continued to swing to 100.5 °to 101.F. 
in the evenings and it was thought better not to give a 
larger dose than 0.15 gm. l'his was therefore continued 
at three day intervals. Artificial pneumothorax induced 
11. 10. 34. Following this, the temperature showed some 
signs of improvement for about a month, but then again 
rose to its previous level. Sputum was now present and on 
16. 11. 34. was found to contain tubercle bacilli. 
Improvement began to take place during January 1935. and 
by the end of February 1935. the temperature was normal 
night and morning, whilst at rest in bed. Sedimentation 
rate still 42. Total Crisalbin to 27. 2. 35. 6.3 gms. 
Temperature rose again on patient being allowed up for 
one hour so that complete rest was once more reverted to. 
Temperature continued to show an evening elevation to 
100.5 °during March and April, 1935. Sedimentation rate 
26. 4. 35. - 52. Sputum positive. 
CASE No. 2 (Cont.) 
Second course of Crisalbin started 2. 5. 35. Dosage: 0.1, 
0.1, 0.15 gm. This latter dose was continued at three 
day intervals. Temperature continued to swing, and the 
patient's general condition got steadily worse. 
X -Ray on 7. 7. 35. showed spread of the disease to 
the left upper lobe. 
Crisalbin stopped 4. 8. 35. Total of second course 
3.0 gm. 
Condition grew steadily worse, the disease showing 
steady progression in the left lung. Artificial 
pneumothorax was stopped on 10. 8. 35. this making no 
difference to the local or systemic symptoms. Both 
lungs showed fresh foci of infections, and the patient 
passed into a state of severe cachexia and died on 17. 11. 35. 
20. 7. 34. 
7. 7. 35. 
- CASE N0,3 
Female, aged 25 years. Admitted 4. 2. 34. 
History of "influenza" two months previously which 
had left her feeling tied and 'run down.' Had been 
troubled with a cough since the attack and lately had been 
bringing up sputum; had noticed herself getting thinner. 
Physical signs: Impairment of percussion note over right 
upper lobe below clavicle; breath sounds bronchial, no 
accompaniments. 
X -Ray: Subclavicular type of infiltration right upper 
lobe. 
General condition poor, weight 7 st. 10 lbs. 
Sputum - positive. Temperature 980 - 99.20'. 





Artificial pneumothorax induced on right side 10. 2. 34. 
and a good collapse obtained. The patient's general 
condition improved steadily. Her sputum after a month 
disappeared altogether and after three months her cough 
also ceased. By 20. 6. 34. she had gained 6 lbs. and was 
up for six hours each day. Her cough again returned, how- 
ever, and in addition her temperature commenced to rise 
again. Her sputum which had ceased, returned, and contained 
tubercle bacilli. 
X -Ray on 2. 7. 34. showed the presence of a new focus 
in the left upper lobe. 
She was put back to bed, and Crisalbin started on 
6. 7. 34. Dosage: 0.025 gm, 0.05, 0.05, 0.1, 0.1, 0.15, 
0.15, 0.25 gm. at three day intervals. 0.25 gm. was 
continued twice weekly until 23. 10. 34. Total 6.25 gm. 
The sputum had become negative on 2. 9. 34. and ceased 
altogether 16. 10. 34. The patient's general condition 
was now very good, weight 8 st. 2 lbs; no cough, no sputum. 
-CASE No. 3 (Cont.) 





No abnormal physical signs could be made out over 
the left lung, but the X -Ray picture was unchanged. 
The patient was discharged on 18. 12. 34. feeling very 
well indeed. Weight 8 st. 5 lbs. 
Second course of Crisalbin started 4. 3. 35. Dosage: 
0.025 gm, 0.05, 0.1, 0.1, 0.15, 0.25 gm. twice weekly. 
0.25 gm. was continued until 28. 6. 35. Total 5. 75 gm. 
The patient was then still 8 st. 5 lbs., and feeling 
very well, no cough or sputum. X -Ray picture still 
showed a good collapse of the right lung and some 
improvement in the left lung. 
A third course similar to the second lasted from 
4. 10. 35. to 27. 1. 36. 
The patient was then feeling so well that leave to work 
as a "sorter" was given. Since then she has continued to 
work regularly and has been symptomless. The right lung 
was allowed to re- expand during April and May 1936. 
On 4. 6. 36. patient was 8 st. 6 lbs, no cough or 
sputum and feeling well. 
X -Ray showed an increased fibrous tissue in the right 
upper lobe, no cavity and no evidence of disease in this 
area; the left apex showed some increase in the normal 
lung striae, but no evidence of active disease. 
CASE 3. 
6. 2. 34.. 
24.. 4.. 36. 
2. 7. 34.. 
CASE No 1 +. 
Female, aged 19 years. Admitted 17. 9. 31f. 
History of febrile illness five weeks before, with 
cough which had persisted, lassitude and loss of weight. 
Physical signs: Impairment over left upper lobe with 
a few post tussic crepitations, breath sounds vesicular. 
Slight impairment above right clavicle. 
X- Ray: Tubercular infiltration left upper lobe with 
early cavity formation; some increase in striae at 
right upper lobe with stippling. 
General condition fairly good. Weight 7 st. 32 lbs. 
Sputum - very scanty; tubercle bacilli present. 





An artificial pneumothorax was induced on the left side 
on 18. 9. 34. and a good collapse obtained. A month after 
the induction, a course of Crisalbin was commenced in order 
to control the disease on the right side. Dosage: 0.025 gm, 
0.05, 0.05, 0.1, 0.1, 0.15, 0.25 gm. at three day 
intervals. 0.25 gm. was continued twice weekly until 
12. 1. 35, a total 6.1 gm. having been given. No reactions 
were experienced and the patient's condition improved 
steadily. Her weight had increased to 7 st. 8 lbs. , and she 
had lost her cough and sputum. She began to be allowed out of 
bed at this time and after six weeks interval, another 
course of Crisalbin similar to the first was given, commencing 
on 22. 2. 35., and finishing on 4. 5. 35, a total of 6.1 óu1. again 
being given. The patient was now up all day; her weight had 
increased to 8 st. 1 lb. and she no longer suffered from 
lassitude, cough or sputum. 





CASE No. t+ (Cont.) 
Physical signs: Nothing abnormal on right side. 
X--Pay: Good collapse of left lung, some increase in 
striae at right apex, no stippling present. 
Patient was discharged on 17. 5. 35. and the following 
month was sent to Davos where she has remained since. A 
report on 19. 6. 36. states that her condition is excellent, 
weight 8 st. 9 lbs, quite free from symptoms, and nothing 
abnormal to be found at the right apex clinically or 
radiologically. Artificial pneumothorax still maintained on 
left side. 
CASE No. 5 . 
Female, aged 2i years. Admitted 8. 6. 34.. 
History of cough and loss of weight for four months; 
lassitude marked. 
Physical signs: Dullness and crepitations over left 
apical region; bronchial "breathing below clavicle. 
X -Ray: Subclavicular infiltration left upper lobe 
with cavity formation; right lung clear. 
General condition poor. /eight 7 st. 52 lbs. 
Temperature 98 °- 99.2 °F. 





Sputum - positive. 
ftin artificial pneumothorax was induced on the left 
side on 22. 6. 34. and a good collapse obtained. The 
patient's general condition improved somewhat following 
this, the temperature tending to settle and weight being 
put on steadily. On 26., 7. 34. however, she had a sudden 
rise of temperature to 103.2 °F. which fell gradually during 
the next five days. This was associated with malaise and 
headache. Following this, the temperature varied between 
98 °and 99.4 °F. and a few post tussic crackles were heard 
at the right apex. An X -Ray picture revealed the presence 
of a new focus in the upper lobe of the right lung and on 
28. 8. 34. a large annular shadow was present. Pneumo- 
thorax treatment was continued and a course of Crisalbin 
was commenced on 4. 9. 34. Dosage: 0.025 gm. 0.025, 0.05, 
0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three day intervals. 
0.025 gm. was then continued twice weekly until 18. 12. 34. 
a total of 5.85 gin. being given. 
The general condition had improved considerably, the 
weight being now 8 st. 122 lbs. The temperature was 
settled but cough still persisted and the sputum still 
contained tubercle bacilli. The sedimentation rate was 
still 32, and an X -Ray picture showed new exudative lesions 
spreading in the right lung. 
CASE No. 5. ¡ Cont.) 
The patient was kept at complete rest and a second 
course of Crisalbin was started on 1. 2. 35. 
Dosage: 0.025 gm. 0.05, 0.1, 0.1, 0.15, 0.25 gm. at three 
day intervals. 0.25 gm. was continued twice weekly for 
four weeks and then the dose was increased to 0.5 gm. 
once weekly for three weeks and subsequently 1.0 gm. 
weekly for two doses. Total 6.275 gin; course completed 
on 3.5. 35. 
There were no reactions and the patient's general 
condition continued good. Weight was now 9 st. 1 ib., 
temperature normal, but an X -Ray showed still further 
spread in the right lung and also in the collapsed lung. 





Because of the obvious spread in the centre lateral 
lung, the artificial pneumothorax was abandoned. This 
did not affect the temperature in any way. This patient 
showed very little systemic reaction to spreading exudative 
disease and obviously very little resistance. 
Discharged on 17. 5. 35. 
After two months at home and ambulant, her weight had 
fallen to 8 st. 6 lbs. and lassitude was marked. Cough 
was troublesome and sputum positive. 
A third course of Crisalbin was started on 24. 7. 35. 
and carried on until 2. 11. 35. Dosage was similar to 
course two, a total of 6.275 gm. being given. 
The weight had now fallen to 8 st. 1 lb. and the sputum 
was still positive. 
An attack of pleurisy supervened on 4. 1. 36. which kept 
the patient in bed for five weeks with a temperature of 
99.6 °E. 
Since then she has steadily lost ground and on 
22. 5. 36. her weight was only 7 st. 8 lbs. No further 
CASE No. 5. (Cont.) 
gold has been given as the patient showed absolutely 
no benefit from its administration, but the disease 
continued to spread. 
A further X -Ray on 22. 5. 36. showed considerable 
extensions in both lungs. 
28. 7. 34. 
28. 8. 34. 22. 5. 36. 
CASE No. 6, 
Female, aged 17 years. History of six months languor 
and loss of weight; cough for two months. 
Physical signs: Impairment of percussion note in 
right apical region above and below clavicle; breath 
sounds bronchial in this area, and a few post tussic 
crepitations heard posteriorly in supra -scapular region. 
X -Ray: Subclavicular type of infiltration right 
upper lobe. Left lung clear. 
Admitted 14. 5. 34. Weight 6 st. 32 lbs. Temperature 
99' F. in the evenings. Sputum - positive. 





Artificial pneumothorax induced on right side 2. 6. 34 
and good collapse attained. Progress satisfactory during 
next two months. Temperature then again rose and the 
sedimentation rate which had fallen to 12, rose again to 
28. X -Ray showed the presence of an early infiltration in 
the middle zone of the left lung. 
Course of Crisalbin commenced 13. 8. 34. Artificial 
pneumothorax continued. 
Dosage: 0.025 gm, 0.05 gm, 0.05 gm, 0.1 gm, 0.1 gm, 
0.15 gm, 0.15 gm, 0.25 gm. at three day intervals. 
Subsequently, doses of 0.25 gm. were continued at three 
day intervals. 
Discharged 4. 2. 35. Total Crisalbin 6.25 gm. 
Condition on Discharge: Weight 7 st. 2 lbs. Afebrile. 
X -Ray: Good collapse of right lung; infiltration 
in left lung of less extent than on 8. 8. 34. 





CASE No. 6 (Cont.) 
Subsequent progress: Second course of Crisalbin 
commenced 8. 5. 35. 5.75 gms. given; dosage 0.25 gm. 
twice weekly; finished 14+. 9. 35. 
Third course commenced 16. 1. 36. 6.0 gms. given; 
similar dosage to second course; finished 10. 5. 36. 
During April and May the artificial pneumothorax was 
allowed to re- expand. 
X -Ray 16. 5. 36. Fibrosis at right apex, and some 
increase in striae in middle zone of left lung, but no 
radiological evidence of active tubercular disease. 
Freight 16. 5. 36. 8 st. 1 lb. General condition 
excellent. No cough or sputum. Doing housework 
regularly with no fatigue. No clinical evidence of any 
active disease in left lung. 
11. 5. 34.. 16. 5. 36. 
CASE NQ: 7 
Female, aged 15 years. Admitted 4. 11. 34. 
History - "pneumonia" six weeks ago which had left 
patient with a cough, considerable loss of weight and 
sweating at night; lassitude marked. 
Physical signs: Signs of consolidation of middle lobe 
with marked bronchial breathing; impairment over left 
upper lobe with showers of fine crackles. 
X -Ray: Dense homogenous shadow throughout middle lobe, 
marked mottling of both upper lobes. 
Sputum - scanty. Tubercle bacilli present. 
General condition very poor. Weight 6 st. 4 lb. 





Temperature 98 °F - 102.6 °F. 
Complete rest in bed was maintained during the first 
two months and no active treatment was adopted, the 
temperature continued to swing between 98 and 102 °F.and 
the general condition remained very poor. 
An artificial pneumothorax was then induced on the right 
side on 7. 1. 35. A complete collapse of the lower lobe was 
obtained with an upward swing towards the middle and 
collapse of the upper lobe. Following this the temperature 
tended to settle more and the general condition improved 
somewhat. A month later (10. 2. 35) small doses of Crisalbin 
were commenced. Dosage: 0.025 gm, 0.025, 0.05, 0.05, 0.1, 
0.15 gm. at three day intervals; 0.15 gm. was continued 
twice weekly during the next two months and then 0.25 gm. was 
given for four weeks, finishing 1. 5. 35; total 4.9 gms. 
The general condition was now very definitely better; weight 
had increased to 6 st. 62 lbs, and the patient had lost her 
sputum, although there was still a morning cough. The 
temperature was normal, and she felt "better than she had for 
months ". 
CASE No. (Copt. ) 
She was now allowed up for a short time, and a second 
course of Crisalbin was started on 2. 7. 35. Dosage: 0.025 gm. 
mounting gradually at three day intervals to 0.25 gm. which 
was continued to 19. 10. 35, a total of 5.15 gm. being 
given. Patient was now up for six hours; her weight had 
increased to 6 st. 11 lbs, temperature normal, no sputum. 
Sedimentation rate had now fallen to 14.. 
A third course of Crisalbin similar to the second was 
started on 2. 1. 36, a total of 5.15 gm. again being given; 
this was completed on 10. 4. 36. 
Patient was now up all day and feeling very well. She 
had still some morning cough, but no sputum. 'Weight had 






Discharged on 19. 4. 36, feeling very well; artificial 
pneumothorax present on right side, considerable improvement 
in physical signs and X -Ray picture on left. 
Examined again on 17. 6. 36, prior to a further course of 
Crisalbin. Improvement maintained, weight increased to 
7 st. 5 lbs. Further improvement in physical signs on left side. 
7. 11. 34. 1. 4. 36. 
CASE No. 8. 
Female, aged 19 years. 
History of loss of weight and languor for three 
months, cough for about eight weeks and sputum for two 
weeks. 
Physical signs: Impairment of percussion at right 
apex to upper margin of second rib in front; at,left 
apex impairment above clavicle; area of dullness below 
angle of right scapula. Breath sounds harsh in right 
apical region with numerous fine crepitations audible 
above clavicle; vesicular over whole of left lung with 
no accompaniments; blowing breath sounds at angle of right 
scapula. 
X -Ray: Mottling at right base with cavity formation; 
increase in striae at both apices with mottling, more 
marked on right side. 
Sputum: Tubercle bacilli present. 
Admitted 8. 5. 34. 'Veight 7 st. 10 lbs. Temperature 
99.5 °F. to 100.1 °F. in evenings. 





Crisalbin started 2. 6. 34. Dosage: 0.025 gm. 0.025, 
0.025, 0.05, 0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm; this 
last dose was continued as a maximum dose. All doses 
given at three day intervals. Total given - 6.5 gm. 
Discharged 14. 12. 34.. 
Condition on Discharge: General condition very good; 
weight 8 st. 8; lbs. Only slight morning cough; sputum 
negative. 
X -Ray: Condition at right base unchanged; no increase 
in extent of apical involvements. 





CASE No. 8 (Cont.) 
Subsequent progress: Second course of Crisalbin 
commenced 8. 3. 35. 0.25 gm. given twice weekly; total 
amount given 5.5 gm. 
Third course commenced 10. 11. 35. 
amount given similar to course two. 
JJosage and total 
Condition on 16. 6. 36: Weight 8 st. 12 lbs'. General 
condition excellent; working as a general housemaid. No 
cough or sputum, afebrile, and feels extremely well. 
Physical signs: Impairment of percussion note in both 
apical regions, breath sounds vesicular, no accompaniments 
audible; breath sounds blowing at angle of right scapula. 
X -Ray: Increase in striae at both apices, no mottling 
now visible; cavity present at right base, but 
considerable clearing of mottling in surrounding lung 
area. 
16. 6. 36. 
CASE No. 9. 
Male, aged 27 years. Admitted 19. 7. 34+. 
History of pleurisy two years ago. Cough for about 
three months, sputum for two months; languor not marked; 
slight loss of weight recently. 
Physical signs: Impairment of percussion over right apex 
and at right base; post tussic crepitations audible at right 
apex anteriorly and posteriorly, also at right base. 
X -Ray: Increase of striae at both apices with stippling, 
more marked at right apex; large annular shadow at right base. 
Sputum - Positive. 





Weight 8 st. 10 lbs. General condition good; slight 
evening pyrexia. 
Course of Crisalbin started 25. 7. 54. Dosage: 0.025 gm, 
0.05, 0.1, 0.15, 0.25 gm, at intervals of three days; 0.25 gm. 
continued at three day intervals until 12. 11. 3. Total 
Crisalbin 6 gm. 
Weight now 9 st. 8 lbs; no accompaniments audible at 
either apex, but still present at right base. No cough, 
slight morning sputum, afebrile. 
Sputum - Negative. 





Discharged 16. 11. 34. 
Second course of Crisalbin started 22. 2. 35. Patient 
now working regularly as a mechanic. Weight 9 st. 6 lbs., 
no cough, slight morning sputum. Sputum negative. 
Dosage: 0.25 gm. twice weekly; total amount given in second 
course 6.5 gm. 
CASE No. 9 (Cont.) 
Condition on 8. 6. 35. 
Weight 8 st. 9 lbs. No cough or sputum; working 
regularly; feeling very well. 
Condition on 10. 6. 36. 
Has not missed a day's work for eighteen months. No 
cough or sputum; feels very fit. Weight 9 st. 12 lbs. 
X -Ray: Increase in striae at both apices, no 
stippling now visible; annular shadow still present at 
right base but very much smaller. 
Physical signs: Impairment at right apex and at 
right base. Breath sounds faint at right base, no 
accompaniments audible. 
12. 7. 34. 10. 6. 36. 
CASE No. 1Q. 
Female, aged 23 years. Admitted 23. 8. 34. 
History of cough and sputum for six months; lassistude 
marked; loss of weight. 
Physical signs: Impairment of percussion over both 
upper lobes; bronchial breath sounds below clavicle on each 
side; numerous moist sounds over upper lobes anteriorly and 
posteriorly. General condition poor. 'sleight 7 st. 92 lbs. 
Sputum positive. Slight evening pyrexia. 
X -Ray: Disseminated foci in both upper lobes, with some 
increase in fibrosis and early cavitation. 





Course of Crisalbin started 23. 8. 34. Dosage: 0.025 gm, 
0.05, 0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three day 
intervals; 0.25 gm. continued twice weekly until 4. 12. 34. 
Total Crisalbin given 6.0 gm. 
General condition improved steadily. Sputum became 
negative on 14.. 10. 34. and remained negative until discharge. 
Discharged 14. 12. 34. General condition much improved; 
sputum reduced from 3 ozs. to 1 oz. negative; weight 8 st.* lb. 





Commenced second course of Crisalbin on 4. 3. 35: finished 
16. 6. 35. Weight then 8 st. 3 lbs, sputum negative. 
Dosage: 0.25 gm. twice weekly. 6.5 gm. given. 
Weight 8 st. 6 lbs; no cough or sputum; feeling very well. 
Condition on 24. 6. 36. 
Weight 8 st. 82 lbs. General condition excellant; feeling 
very well and doing housework regularly; no cough or sputum. 
CASE No.10 (Cont.) 
Physical signs: Impairment of percussion over both 
upper lobes, with harsh breath sounds; a few post tussic 
crepitations over right apex posteriorly. 
X -Ray: Marked fibrosis throughout both upper lobes. 
Considerable radiological improvement. 
15. 8. 34. 21f. 6. 36. 
CASE No. 11. 
Male, aged 26 years. Admitted 2. 5. 34. 
History of lassitude for three months, with cough and 
sputum during the past month and a small haemoptysis 
three days before admission. 
Physical signs: Dullness with post tussic crepitations 
at both apices. 
X -Ray: Infiltrations with some fibrosis in both upper 
lobes. 
General condition fairly good. Weight 9 st. 2 lbs. 
Sputum - positive. Temperature 98°- 99.2°7. 





Crisalbin started 15. 5. 34. Dosage: 0.025 gm. 0.05, 
0.1, 0.1, 0.15, 0.25 gm. at three day intervals. 0.25 gm. 
was continued until 28. 8. 34, a total of 6.075 gm. being 
given. 
Patient's Weight had increased to 9 st. 12 lbs. Sputum 
was now negative, and the temperature was normal. He was 
allowed up, and a second course was commenced on 4.. 10. 34.. 
lasting till 18. 12. 34. Dosage similar to course one, 
total 5.625 gm. 
Discharged 22. 12. 34. 





Weight 10 st. 4 lbs. No cough or sputum. 
He returned to his work as a "packer" in an electrical 
firm on 4.. 2. 35. and has worked regularly since. Another 
course of Crisalbin similar to courses one and two was 
given from 2. 4. 35. to 10. 7. 35. Total 6.1 gm. 
CASE No. 11 (Cont.) 
The physical signs had now improved, no moisture being 
audible, and in the X -Ray picture, there was absorption 
of much exudate. 
On 7. 7. 36. the patient was still working. His weight 
was 10 st. 11 lbs., no cough or sputum and feeling well. 
An X--Ray showed only fibrosis at both apices' and there 
was no clinical evidence of activity. 
19. 5. 34. 7. 7. 36. 
OASE No. 12. 
1 emale, aged 22 years. Admitted 14. 5. 34. 
History of six months cough and sputum with gradual 
loss of weight. A small haemoptysis one week before 
admission. 
Physical signs: Impairment of percussion over both 
upper lobes with bronchial breathing and numerous 
crackling crepitations. 
X -?day: Extensive tubercular infiltrations in both 
upper lobes with some fibrosis in left upper. 
General condition poor. Weight 7 st. 12 lbs. 
Sputum - positive. Temperature 98.2°- 99.6 °F. 





Crisalbin started 22. 5. 34. Dosage: 0.025 gm, 0.025, 0.05, 
0.1, 0.1, 0.15, 0.25 gm. at three day intervals. 0.25 gm. 
was continued twice weekly until 4. 9. 34. Total 6.05 gm. 
General condition had improved considerably; weight 
increased to 8 st. 4 lbs. Temperature normal. Sputum had 
decreased in amount and was now negative. Sedimentation 
rate 9. 
A second course was commenced on 16. 11. 34. with the 
same dosage as course one. Total to 4. 3. 35, 6.05 gm. 
Weight had now increased to 8 st. 11 lbs. Temperature 
normal. Sputum had ceased altogether, although a slight 
dry cough persisted. The patient was now up eight hours 
and felt extremely well. Physical signs showed some 
improvement. 





CASE No. 12 (Cont.) 
Discharged on 17. 3. 35. 
Third course of Crisalbin 20. 5. 35. to 4. 9. 35. 
Dosage similar to course one and two, total of 6.3 gm. given. 
Weight at end of course 9 st. 4. lbs. Some dry cough still 
present. 
T+ourth course of Crisalbin 23. 11. 35. to 2. 3. 36. 
Dosage as in course three, total of 6.3 gm. given. Weight 
now 9 st. 10 lbs, feeling extremely well. No cough or 
sputum, but some dyspnoea on exertion. 
Physical signs: Some impairment of percussion over right 
upper lobe, breath sounds vesicular, no accompaniments; 
impairment over left upper lobe with harsh vesicular breathing; 
no accompaniments. 
X -Ray: Right lung clear. Some fibrosis of left upper 
and lower lobes with traction of mediastinum to the left. 
12. 5. 34.. 8. 4.. 36. 
CASE No.13. 
Female, aged 23 years. Admitted 19. 6. 34. 
History of two months cough, following pleurisy, with 
loss of weight and feeling of being run down. General 
condition fairly good. "-eight 7 st. 132 lbs. Sputum 
positive. 
Physical signs: Impairment of percussion over whole of 
right upper lobe and also left apex. Breath sounds 
vesicular in both areas but numerous post tussic 
crepitations audible. 
X -Ray: Extensive infiltration in right upper lobe; 
increase in striae with mottling at left apex. Temperature 
98.6 °F. in evenings. 





Artificial pneumothorax attempted on right side, but 
failed owing to numerous adhesions. 
Coarse of Crisalbin started on 6. 7. 34. Dosage: 0.025 gm. 
0.025, 0.05, 0.05, 0.1, 0.15, 0.15, 0.25 gm. at three day 
intervals; 0.25 gm. continued twice weekly until 27. 10. 34. 
Total 6.25 gm. 
Sputum reduced from 2 oz. to 1 dram; no tubercle bacilli 
found. 
Weight increased to 8 st. 10 lbs. General condition 
excellent. 





Discharged 20. 11. 34. 
CASE No.13 (Cont.) 
Weight 9 st. 32 lbs. No cough or sputum, and feeling 
extremely well. X -Ray showed considerable absorption of 
infiltrates in right upper lobe. 
Second course of Crisalbin started 8. 2. 35. Dosage: 0.25 gm 
twice weekly. Total 5.75 gm; course finished on 22. 5. 35. 
Weight had increased to 9 st. 8 lbs; no cough or, sputum, and 
doing housework regularly. 
Condition on 4. 6. 36. 
Weight 9 st. 102 lbs; feeling extremely well; and 
working regularly; no cough or sputum. 
Physical signs: Impairment and retraction over right 
upper lobe, some impairment at left apex. Harsh breath 
sounds at both apices, no accompaniments audible. 
X -Ray: Considerable fibrosis in right upper lobe but 
no radiological evidence of activity; increase in striae 
at left apex. 
22. 6. 34. 4. 6. 36. 
CASE 14. 
Female, aged 19 years. 
This patient was first seen on 17. 5. 31f. 
History: Lassitude for several months. Cough and 
spit for past two months and a haemoptysis on 10. 5. 34. 
Physical signs: Dullness at left apex with 'a few fine 
post tussic crepitations posteriorly. 
X -Ray: Subclavicular infiltration in upper left lobe. 
General condition poor. -'-eight 7 st. 6 lbs. 
Temperature in evenings 99 °F. 
Sputum - positive. 
She was sent to a private sanatorium on 25. 5. 34. 
where an artificial pneumothorax was attempted but failed. 
After this, she had the usual sanatorium regime of rest 
and graded exercises. She was discharged on 21. 12. 34. 
and was examined again on 23. 12. 34. The general 
condition had improved somewhat, the weight now being 
7 st. 10 lbs. and the patient felt "a little better ". 
On physical examination, there was considerable spread 
in the disease in the upper left lobe with cavity 
formation at the apex. 
Sputum - positive. 
She was admitted to Holly Lane Sanatorium on 6. 1. 35. 





Crisalbin was commenced on 14. 1. 35. Dosage: 0.025 gm. 
0.025, 0.05, 0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three 
day intervals. 0.25 gm. was then continued twice weekly 
until 25. 4. 35. Total 6.15 gm. 
CASE No. 11+ (Cont.) 
The weight had now increased to 8 st. 1 lb. and the 
sputum was negative. 
The patient was allowed to get up for a short time 
each day. A second course of Crisalbin, similar to 
the first, lasted from 19. 6. 35. to 2. 10. 35. Total 
6.2 gm. 
The general condition was now much better. Weight 
8 st. 6 lbs. No cough and no sputum. Where was definite 
improvement in the physical signs and X -Ray picture. 





Discharged 10. 10. 35. 
A third course similar to the first two lasted from 
4+. 1. 36. to 
The weight was now 8 st. 13 lbs. No cough or sputum 
and feeling very well. There was still evidence on physical 
examination of a cavity at the left apex, but there were 
no accompaniments audible. 
The X -Ray picture had improved considerably. The 
infiltrations in the left upper lobe had been almost 
completely absorbed, and there was a thin walled cavity 
at the apex. 
A phrenicectomy was performed on 30. 4. 36. 
Another course of Crisalbin was started on 16. 6. 36. 
and it is proposed that following the completion of this 
course, a plastic operation be performed to collapse the 
cavity in the upper lobe. 
CASE 14.. 
17. 5. 34.. 
6. 1. 35. 16. t+. 36. 
CASE No. 15. 
Male, aged 17 years. Admitted 8. 11. 34. 
History of pleurisy six weeks before. Cough had 
persisted and there was marked lassitude. 
General condition poor. Weight 8 st. 82 lbs. 
Temperature 98 °- 100 °F. Sputum - positive. 





Physical sings: Dullness over upper left lobe and 
upper part of left lower lobe; breath sounds vesicular, 
numerous fine crepitations. Right apex impaired with a 
few post tussic crepitations. 
X -Ray: Disseminated nodules throughout left lung 
and right upper lobe. 
Crisalbin started 18. 11. 34. Dosage: 0.025 gm. 
0.025, 0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three day 
intervals. 0.25 gm. was continued twice weekly until 
2. 3. 35. a total of 6.15 gm. being given. 
The temperature was now normal and the sputum had 
become negative. There was still a dry cough, but the 
general condition had improved greatly. Weight had 
increased to 9 st. 54 lbs. 
The patient was allowed up and a second course similar 
to the first was commenced on 19. 4. 35 and continued 
to 6. 6. 35. when a rash appeared. The rash was of maculo- 
papulo squamous type and tended to form large patches on 
the trunk and extensor surfaces of the arms; it was bright 
red in colour, but toned down to a dull reddish brown 
colour. There was no rise of temperature and no malaise. 
The patches did not fade in the usual way, but tended to 
become indurated and raised above the level of the 
surrounding skin. They gradually assumed a yellowish brown 
colour, and at the time of discharge were present on the 
front and back of the trunk in patches about two inches 
in circumference and on the backs of the forearms. 
CASE No. 15 (Cont.) 
Discharged 14. 8. 35. 
Weight 9 st. 82 lbs. No cough and no sputum. 
Sedimentation Rate 12. 
Polymorphs 70iß 
Lymphocytes 24% 
Mononuclears , 4l 
Eosinophils 2yá 
There was definite improvement in the physical signs 
and the X -Ray picture. 
The patient started work on 2. 2. 36. as motor mechanic 
and has worked steadily since then. 
On 7. 7. 36. on physical examination, although dullness 
existed in the original areas, no accompaniments could now 
be heard and breath sounds were vesicular in character. 
Weight was 10 st. 4 lbs. and the patient was feeling very 
well; no cough or sputum. 
The X -Ray showed considerable clearing of the exudations 
and increase of fibrosis in both lungs. 
The rash was still present but much fainter, being now 
a dirty yellow staining of the skin, and no longer raised. 
12. 11. 34. 7. 7. 36. 
CASE No. 16. 
Female, aged 16 -ears. Admitted 3. 8. 34. 
History of a profuse haemoptysis two days before 
admission. Had been feeling perfectly well before this, and 
working without fatigue as a domestic servant; no cough 
or sputum. 
Physical signs: Impairment of percussion over the 
right upper lobe, breath sounds vesicular with numerous fine 
crackles; impairment over left apex, with a few post tussic 
crepitations. 
X -Ray: Tubercular infiltration right upp.r lobe with 
mottling at left apex. 
General condition fairly good. Weight 5 st. 11* lbs. 
Sputum - nil. Temperature 98 °- 98.6 °F. 





Crisalbin started 15. 8. 34. Dosage: 0.025 gm, 0.025, 
0.05, 0.05, 0. 1, 0.15, 0.15, 0.25 gm. at three day intervals. 
0.25 gm. was continued twice weekly until 1. 12. 34. Total 
6.15 gm. being given. 
The patient's weight had incrased to 6 st. 4 lbs; she was 
feeling perfectly well, no cough, no sputum, temperature 
normal. Sedimentation rate 12. She was, however, kept 
completely at rest in bed and another course was commenced 
on 27. 1. 35. Dosage was similar to course one, a total 
of 6.3 gm. being given, finishing on 4. 4. 35. During this 
course, the patient was gradually allowed up, until at its 
completion, she was up for eight hours without any reactions. 
She was discharged on 16. 4. 35. feeling extremely well. 
Her weight had now increased to 6 st. 10 lbs; no cough, 
no sputum. 





CASK. No. ] 6 (Cont.) 
The physical signs had improved, no moisture being 
now audible in either lung. 
X -Par showed improvement in both lungs. 
On leaving sanatorium, patient returned to her home on 
a farm in Shropshire. On enquiry on 7. 6. 36. the patient 
reports that she is keeping very well and doing some 
light housework. She had then no cough or sputum and her 
weight was 7 st. 4- lbs. 
14. 8. 34. 14. 4. 35. 
CASE No.17. 
Male, aged 24 years. Admitted 4. 8. 34. 
History of cough, sputum, lassitude and loss of weight 
for eight months. 
Physical signs: Marked impairment of percussion note 
over whole of left upper lobe, apex of left lower, and apex 
of right upper lobe. Signs of cavitation in left upper lobe 
and many moist sounds throughout lung; breath sounds blowing 
at right apex, and showers of post tussic crackles through- 
out right upper lobe. 
X -Ray: Extensive infiltrations throughout left lung 
with cavitation in upper lobe; right upper lobe 
extensively involved. 
General condition very poor. Evening temperature 101 °F. 
Sputum - positive. 





After three weeks complete rest in bed., the temperature 
fell to 99 °F. in the evening. 
Course of Crisalbin started 29. 8. 34. Dosage: 0.025 gm, 
0.025, 0.05, 0.05, 0.05, 0.1 gm. at three day intervals. 
0.1 gm. was continued biweekly until 29. 10. 34. total 1.3 gm., 
when an erythematous rash appeared on trunk and limbs, the 
temperature rising to 100.5 for four days. Treated with 
Contramine. 
The blood count at this time showed a total polymorph 
percentage of 76 of which 24. per cent were eosinophils. 
Sediment:. tion rate was 60. 
The rash disappeared in six days, and the temperature settled 
to 98.2 in the evenings. The weight at this time was 
10 st. 3 lbs. Sputum positive. 
A rest of a month from injections was given, at the end 
of which, the polymorph percentage was still 74, but the 
eosinophils had fallen to 12 per cent. 
CASE No. 17 (Cont.) 
A dose of 0.025 gm. Crisalbin was then given in 
10 cc. Calcium gluconate. The next day the eosinophils 
had risen again to 22ÿ0 and the following day an 
erythematous rash again appeared, with a rise of 
temperature. This was again treated with Contramine as 
before, and the temperature settled in two days, the rash 
persisting this time for six days. 
No further Crisalbin was given in this case. 
The patient was discharged on 8. 4. 35, at his own 
request. The weight was then 10 st. 4 lbs; sputum was 
still positive, and the physical signs showed very little 
change. The general condition had improved considerably; 
there was no radiological change obvious. 





After discharge, he began to lose weight steadily, his 
general condition deteriorating rapidly. 
On 21. 6. 35. he was only 8 st. 10 lbs. and chest 
showed new spread of the disease with cavitation in the 
right upper lobe. Sputum positive. 
From that date he was confined to bed at home. His 
condition continued to deteriorate and he died on 23. 11. 35. 
10. 10. 34. 
CASE No. 18. 
Female, aged 26 years. Admitted 4. 9. 34. 
History of "influenza ", ten months previously from 
which she had never fully recovered, having been left 
with a cough and a tired feeling; during the three months 
before admission, she had been losing weight steadily, 
and lately had had a pain in the right side when taking 
a deep breath. 
Physical signs: Signs of extensive consolidation in 
right upper lobe with cavitation at apex; breath sounds 
over middle and lower lobes harsh with numerous post 
tussic crepitations; impairment on percussion at left 
apex to lower border of second rib with bronchial 
breath sounds and fine crepitations. 
General condition poor. Weight 8 st. 10 lbs. 
X -Ray: Extensive tubercular involvement of right 
upper lobe with cavitation; disseminated disease in 
middle and right lower lobes; left upper lobe shows 
mottling above and below clavicle. 
Sputum - positive. 





Temperature 98° - 99.6 °F. 
Artificical pneumothorax attempted on right side but 
a good collapse not obtained owing to wide spread 
adhesions; it was, therefore, abandoned. 
Course of Crisalbin started 11. 10. 34.. Dosage: 0.025 gm 
0.025, 0.05, 0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three 
day intervals. 0.025 gm. was continued twice weekly until 
4. 2. 35. Total 5.75 gm. 
The patient's general condition at the end of the course 
was if anything slightly worse. Her weight had fallen to 
8st. l lbs., her sputum was unaltered in amount and still 
contained tubercle bacilli. 
CASE No. 18 (Cont.) 
She had been completely in bed during this period and 
her temperature had declined, but still tended to rise 
to 99 °F. occasionally in the evening. The sedimentation 
rate was 40 at the end of the course, and there had been 
no appreciable alteration in the polymorph, lymphocyte, 
mononuclear ratio. The physical signs showed some 
extension of the disease in the left upper lobe'and the 
X -Ray picture was definitely worse than on admission. 
After a further oeriod of two months complete rest, a 
second course of Crisalbin was started. Dosage to 
commence with was the same as course one, but was increased 
after four doses of 0.25 gm. to one dose of 0.5 gm. 
weekly for three weeks, 0.75 gin. weekly for three weeks, 
and one dose of 1 gm. Following this latter dose the 
patient developed some stomatitis and diarrhoea, which 
persisted for a week. Her temperature was settled but her 
general condition at the end of the course (14. 8. 35) was 
unaltered. The weight was 8 st. 2 lbs, sedimentation rate 
34, blood picture unaltered, sputum positive. 
Physical signs showed even more extensive disease in 
the left lung than previously. The X -Ray picture showed 
extension of the disease in both lungs. 
The patient was discharged on 4. 10. 35. at her own 
request. Her weight was then 8 st. 3 lbs. 





On returning home her condition grew steadily worse. 
She lost weight, suffered from occasional attacks of 
diarrhoea, and in January 1936. became very hoarse. There 
was tenderness over the ascending colon, and undoubtedly 
an intestinal tuberculosis was present. 
The patient died on 18. 3. 36. 
CAS''] 18. 
6. 9. 34-. 
8. 2. 35. 18. 12. 35. 
CASE No. 19. 
Female, aged 17 years. Admitted 1. 5. 34-. 
History of 'Influenzal attack' three months previously 
which had left patient feeling very weak. She had lost 
weight steadily and had a very troublesome cough with scanty 
sputum. 
Physical sings: Signs of extensive tubercular 
involvement of both upper lobes. 
X -Ray: Tubercular infiltrations throughout both upper 
lobes with early cavitation. 
General condition very poor. 'Weight 6 st. 92 lbs. 
Sputum - positive. Temperature 98° - 100.4 °F. 





Crisalbin started 5. 5. 34-. Dosage: 0.025 gm, 0.025, 
0.05, at three day intervals. A febrile reaction lasting 
two days followed the third dose; a weeks interval was, 
therefore given, followed by 0.025 gm, 0.025, 0.025, 0.05, 
0.05, 0.1 gm, again at three day intervals. Another febrile 
reaction, shorter than the first, followed the dose of 0.1 gm. 
After another week, dosage was recommenced again at 0.025 gm, 
and increased to 0.25 gm, without further incident. This 
dose was continued twice weekly and 6.025 gm. had been given. 
The course lasted till 30. 10. 34. The patient's general 
condition was definitely better. eight had increased to 
7 st., and the sputum had become negative. The temperature 
was normal, the patient being at rest in bed. The 
sedimentation rate had fallen to 22. 
Two months. rest was allowed, the patient still being at 
complete rest in bed, and then another course was given, 
starting on 2. 1. 35. Dosage: Starting at 0.025 gm, dosage 
was increased gradually to 0.25 gm, with three day intervals, 
there being no reactions. A total of 6 gm. was given. The 
general conditon had improved considerably, weight on 
14. 4. 35. at the end of the second course,being 7 st. 7 lbs. 
Sputum had ceased and there was only a slight dry cough. 
The X -Pay picture had improved considerably. 
CASE No. 19 Cont.) 





Temperature - normal. 
The patient was now allowed up, and was discharged 
on 27. 7. 35. 
A third course of Crisalbin was started on 2. 9. 35. 
Dosage: 0.025 gm, increasing steadily to 0.25 gm, this 
dose being continued twice weekly until 18. 12. 35, a total 
of 5.5 gm. being given. The patient was now 8 st. 1 lb. 
and was feeling extremely well. Slight dry cough still 
persisted. 
A fourth course with dosage similar to the third, was 
commenced on 4. 2. 36. and finished on 24. 5. 36. The 
patient's weight was now 8 st. 12 lbs. Slight morning 
cough persisted, but no sputum and she felt very well 
indeed, being able to walk five miles per day with no feeling 
of exhaustion. 
The X -Ray picture showed considerable absorption of 
the infiltrations in both lungs, and a considerable amount 
of fibrous tissue formation taking place. 
8. 5. 34. 27. 6. 36. 
CASE r 2Q .. , . 
Female, aged 18 years. Admitted 31. 9. 34 -. 
History of four months cough, spit and lassitude. 
Physical signs: Signs of extensive disease throughout 
both lungs, more marked on the left side. 
X -Ray picture showed extensive lesions in both lungs, 
with some fibrosis on left side and traction of mediastinum 
to that side. 
General condition poor. `eight 7 st. 2 lbs. 
Sputum - positive. Temperature 98°- 98.8°F. 





Crisalbin started 14. 10. 34. Dosage: 0.025 gm. 0.025, 
0.05. 0.05, 0.1, 0.1, 0.15, 0.15, 0.25 gm. at three day 
intervals. 0.25 gm. was continued twice weekly. After 
a total of 1.9 gm. had been given, a scarlitinaform rash 
appeared which lasted six days. Two weeks rest was given 
and the course recommenced with doses of 0.025 gm. There 
were no further reactions and the course was finished on 
26. 2. 35, a total of 6.305 gm. having been given. 
The general condition was improved and the patient felt 
much better; the tempert:ture was normal but the pulse 
rate varied between 90 and 100 at rest in bed. The physical 
signs were unchanged and the X -Ray picture showed further 
spread of the disease. Sedimentation rate 39. Cough 
was still present and the sputum was still positive. 
Patient was kept at complete rest and a second course 
of Crisalbin was started on 17. 4. 35. Dosage: 0.025 gm. 
0.05, 0.05, 0.1, 0.15, 0.15, 0.25 gm. at three day 
intervals. 0.25 gm. twice weekly was then continued for 
four weeks. 0.5 gm. was then given weekly for four weeks 
and 1.0 gm. weekly for two weeks. Total to 14. 8. 35. 
6.775 gm. 
Weight had now increased to 7 st. 134 lbs. Cough was 
still present but sputum had ceased. 
CASE No. 20 (Cont.) 
Temperature normal but pulse still varied between 90 -100. 





X -Ray picture showed still further extension of the 
disease in both lungs. There was remarkably little 
systemic reaction when the extent and spread of the disease 
was considered. 
Discharged 26. 8. 35. 
After two months at home, the weight had fallen to 
7 st. 8 lbs. and sputum had returned, and contained 
tubercle bacilli. 
A third course of Crisalbin similar to course two was 
given from 9. 11. 35. to 4. 3. 36. Total 6.775 gm. 
The weight had now fallen to 7 st. 41b. There was 
further radiological evidence of extension of the disease 
and lassitude was marked. In spite of this, there was 
no temperature, but the pulse rate averaged 110. 
From 5. 4+. 36. the patient was confined to bed, and 
continued to waste steadily. She died on 13. 7. 36. 
2. 10. 34. 29. 2. 36. 
CASE No. 21. 
Male, aged 41 years. Admitted 24. 5. 34. 
History of cough, "wheezing" and some sputum for seven 
months; loss of weight and lassitude during past eight 
weeks. 
Physical signs: Impairment of percussion over whole of 
right upper lobe and right apex to upper border of second rib. 
Breath sounds harsh vesicular; numerous moist sounds at both 
apices. 
X -Ray: Tubercular fibrosis both upper lobes, more 
marked on right side. 
Weight 7 st. 12 lbs. General condition poor. 





Sputum - positive. Evening temperature 98.40F. 
Crisalbin started 5. 6. 34. Dosage: 0.025 gm, 0.05, 0.1, 
0.15, 0.25 gm. at three day intervals. 0.25 gm. continued 
twice weekly until 27. 9. 34. Total 6 gm. 
General condition improved steadily. Sputum became 
negative on 20. 8. 34. and was absent altogether by the end 
of the course. Cough also disappeared and the weight 
increased to 9 st. 22 lbs. No moisture now audible in either 
lung. 





Discharged 18. 10. 34. 
Started work again on 7. 1. 35. and has worked regularly 
ever since, as a mechanic. 
Second course of Crisalbin given from 2. 3. 35. to 10. 6. 35. 
Dosage: 0.25 gm. twice weekly. Total 6.5 gm. 
CASE No. 21 (Cont.) 
Has remained well since discharge. On 21. ¿. 36. the 
general condition was excellent; weight 9 st. 8 lbs; no 
cough or sputum; slight dyspnoea on exertion but otherwise 
felt very well. 
Physical signs: Impairment and retraction over right 
upper lobe; some impairment at left apex. Breath sounds 
harsh vesicular; no accompaniments. 
X -Ray: Increased fibrosis in both upper lobes; no 
radiological evidence of activity. 
4. 6. 3 4.. 21. 4.. 36. 
CASE No. 22. 
Male, aged 34 years. Admitted 18. 1. 35. 
History of six months cough, sputum, loss of weight, 
lassitude, night sweats and dyspnoea. 
Physical signs: Signs of extensive fibro caseous disease 
in both lungs. 
X -Ray: Extensive tubercular involvement both lungs with 
cavitation at left apex. 
Sputum - positive. 
General condition poor. Weight 9 st. 7 lbs. Evening 
temperature 100 to 100.6 °F. 





Crisalbin started 30. 1. 35. Dosage: 0.025 gm, 0.025, 0.05 
0.05, 0.1, 0.1, 0.15, 0.15, 0.15, 0.25 gm. at three day 
intervals. 0.25 gm. continued twice weekly until 3. 4. 35; 
total amount given 6.15 gm. 
Temperature became more settled, but still tended to 
rise occasionally to 98.8 °F. in the evening. Weight increased 
to 9 st. 13 lbs. but there was no real improvement in the 
general condition. Sputum remained unchanged in amount and 
in bacillary content. 











X -Ray: No improvement in lung condition seen. 
Second course of Crisalbin commenced 22. 7. 35; general 
condition had deteriorated since discharge and weight was now 
9 st. 4 lbs., but readmission to sanatorium was refused. 
CASE No. 22 (Cont.) 
Dosage: 0.15 gm, 0.15, 0.25. twice weekly; 0.25 gm. 
continued twice weekly for a month - total given 2.55 gm. 
It was obvious this patient was going quickly down hill; 
he was confined to bed at home on 31. 8. 35, again 
refusing sanatorium. His condition grew steadily worse 
and he died on 25. 1. 36. 
5. 2. 35. 18. 6. 35. 
CASE No. 23. 
Male, aged 44 years. Admitted 9. 10. 34. 
History: First diagnosed as suffering from pulmonary 
tuberculosis in 1925. Fibroid type of case-and had 
remained well, although troubled with a dry cough, and 
shortness of breath. During the past six months he had 
began to lose weight and suffer from lassitude. Recently 
had begun to have a spit as well as a cough. 
Physical signs: Signs of old standing bilateral 
disease with cavitation at left apex. Signs of activity 
in both upper lobes. 
General condition poor. Weight 9 st. 41b. 
Temperature 97.8 °to 99.4 °F. 
Sputum - positive. 
X- Ray: Old standing tubercular fibrosis of both 
lungs with cavitation at left apex; more recent infiltrations 
in middle zone of left lung and in right upper lobe. 





A course of Crisalbin was started on 18. 10. 34. 
Dosage: 0.025 gm. 0.025, 0.05, 0.1, 0.1, 0.15, 0.25 gm. 
at three day intervals. 0.25 gm. was then continued 
until 9. 1. 35. when diarrhoea developed. This settled 
down within three days. Total given 4.2 gm. 
The temperature was now settled; weight had increased 
to 9 st. 6 lbs. and the sputum was negative. 
The patient was allowed up and a second course of 
Crisalbin was started from 2. 3. 35. to 13. 6. 35. Dosage 
similar to course one, a total of 6.15 gm. being given. 
The physical signs were somewhat improved and the X -Pay 
Picture showed some slight improvement. Sputum negative. 





CASE No. 23 (Cont.) 
Discharged 20. 6. 35. 
Third course of Crisalbin 18. 8. 35. to 2. 12. 35. 
Dosage similar to courses one and two, a total of 6.15 gm. 
being given. 
At the end of the course the weight was 10 st.' 2 lbs. 
Cough was still present, but the sputum had ceased, and 
the patient was feeling very well. He returned to work 
as a clerk on 1. 2. 36. and has been working ever since. 
On 17. 6. 36. the weight was 10 st. L- lbs. No sputum 
present and feeling very well. 
The physical signs still showed some activity at both 
apices, but were much improved. 
X -stay showed some slight increase in fibrosis. 
20. 10. -3L;.e 
CASE No. 24. 
Female, aged 43 years. Admitted 26. 11. 34. 
History of chronic cough for years. During last 
six months, patient had left run down and had lost nearly 
a stone in weight. Sputum had been copious during last 
few months. 
Physical signs: Impairment of percussion over both 
upper lobes with signs of cavitation at left apex; 
numerous coarse crepitations throught both upper lobes. 
X -Pay: Extensive tubercular fibrosis of both upper 
lobes with cavitation in left upper. 
General condition fairly good. Weight 7 st. 8ä lbs. 





Sputum - positive. Temperature 97 °- 98.8 °?. 
Crisalbin started 2. 12. 34. Dosage: 0.025 gm, 0.05, 0.1, 
0.15, 0.25 gm. at three day intervals. 0.25 gm. was 
continued twice weekly untill4. 3. 35. Total 6.15 gm. 
Sputum had decreased in amount and was now negative. 
Weight had increased to 8 st. 3 lbs. Sedimentation rate 13. 
Patient was allowed up and a second course of Crisalbin 
was started on 7. 5. 35. This was similar to course one and 
finished on 28. 8. 35. Total 6.15 gm. 
Patient was feeling very well. Cough was not troublesome 
and sputum was less, mucoid, and negative. 





Weight had increased to 8 st. 7 lbs. 
CACE No. 2 (Cont.) 
Discharged 1+. 9. 35. 
Third course Crisalbin 2. 2. 35. to 16. 5. 35. Dosage 
similar to courses one and two; total 6.15 gm. 
Weight now 8 st. 10 lbs. Cough not troublesome, sputum 
negative, feeling very well, and doing her housework 
regularly. 
Physical signs showed considerable improvement. 
X -Ray: Extensive tubercular fibrosis throughout left 
lung; some increase in fibrosis in right upper lobe. 
4. 6. 36. 
RESULTS OF TREATMENT. 
(a) Cases treated by artificial pneumothorax and Crisalbin. 
There are seven cases in this group, Nos. 1 to 7 
in the series. Three of these, Nos. 1, 4 and 7, had 
bilateral disease when first they came under treatment. 
All have shown improvement and in none has there been 
any spread of disease in the uncollapsed lung. In the 
case of No.1, all evidence of active disease in the 
contralateral lung has disappeared leaving only some 
scarring seen on radiological examination. The 
pneumothorax in this case is still being carried on, 
but the patient has been doing hard work for more than 
a year and his condition and muscular tone are 
excellent. 
Case No. 4. has also lost all evidence of active 
disease in the contralateral lung. Her artificial 
pneumothorax is also being carried on. 
Case No. 7. is one of a very young girl with a 
spreading type of disease in both lungs. Whilst the 
ultimate prognosis in this case must still remain very 
doubtful, there is no question but that she has 
obtained considerable benefit from gold therapy. The 
disease in the uncollapsed lung has not spread, but 
indeed has shown a tendency to absorption. This is the 
- 38 - 
type of case which without treatment one would expect 
to proceed fairly rapidly to a fatal end, and it 
seems very gratifying that the patient should have 
improved so considerably, even although the future 
must remain as yet uncertain. 
Cases Nos. 2, 3, 5 and 6 were.all unilateral 
when first seen and were treated primarily by artificial 
pneumothorax, but all had a subsequent spread of the 
disease to the uncollapsed lung. Nos. 3 and 6 have 
since had their pneumothorax treatment discontinued 
and both are working, the former earning her living 
in a factory and the latter doing housework. In 
neither is there any evidence of active disease in 
the lung which was collapsed or in the contralateral 
lung. 
Cases 2 and 5 have not such a fortunate history 
as the others in this group. Case 2 had a spread of 
disease to the contralateral lung subsequent to the 
collapse of the one originally infected, and the 
disease then continued to spread in both lungs. 
Absolutely no benefit was shown from gold therapy in 
this case which had a fatal termination. The patient 
came of very bad stock and had been exposed to massive 
infection in the house, both her father and elder sister 
being cases of open pulmonary tuberculosis with positive 
sputa. 
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Case 5 has a like history, the subsequent spread 
of disease to the uncollapsed lung being quite 
unaffected by gold therapy and necessitating the 
abandonment of the pneumothorax threatment. Subsequent 
curses of gold injections had likewise no effect, and 
a fatal termination of this case is only a matter of 
time. 
In five out of seven cases, therefore, gold 
therapy has controlled a spread in the uncollapsed 
lung and in four of these, all evidence of such active 
spread has disappeared. One case of this group is dead, 
and one is worse. 
(b) Cases of fresh spreading exudative disease treated by 
Crisalbin alone. 
In this group, there are thirteen cases, 
Nos. 8 to 20. All the patients were young and all, 
with one exception (Case 11+ ),had bilateral disease. In 
two other cases, Nos. 13 and 18, the extent of the 
disease in the better lung did not preclude collapse 
of the worse lung, but in all three cases, artificial 
pneumothorax treatment failed owing to numerous adhesions, 
and gold therapy had to be fallen back upon as the first 
line of treatment. 
Cases 10, 11 and 12 were a mixture of nodular 
productive, and exudative lesions, all the others in 
this group were purely exudative. Cases 17, 18, 19 and 20 
- 1,0 - 
were very widespread lesions and the patients were 
exceeding toxic when they first came under observation. 
Cases 8 and 9 bear a close resemblance to each 
other clinically. Both had a bilateral apical 
involvement with basal annular shadows. Both cáses 
have shown a steady improvement in the apical condition 
until now no evidence of active disease in these areas 
remains. The annular shadows however, still persist 
in both cases, but now the condition is amenable to 
collapse therapy either in the form of artificial 
pneumothorax or localised thoracoplasty combined with 
phrenicectomy if necessary. In both cases, however, the 
patients are quite symptomless and both are working 
without any ill effects, so that it is felt a further 
period of observation is justified before deciding on 
any radical form of treatment. 
The productive and exudative cases,(Nos. 10,11 and 
12) have all responded in a most satisfactory way to 
treatment, and all three have shown absorption of 
exudate and transformation of the productive lesions into 
fibrous tissue in a most marked degree. 
Cases 13 and 15 have likewise shown an absorption 
of exudate and formation of fibrous tissue to an extent 
only slightly less marked than that of the proceeding 
three cases. 
Case 11+ has responded to treatment in a way which 
has altered her whole prognosis. In spite of the fact 
that a large cavity was present at the apex of one upper 
lobe, the exudative disease in the surrounding lung 
tissue has undergone resolution and enabled a 
thoracoplastic operation to be considered in order to 
obliterate the cavitation. The patient's improved 
condition and the type of local lesion remaining, make 
the results to be expected from such a proceedure, most 
hopeful. Before gold therapy was instituted, the course 
had been a downward one in spite of routine sanatorium 
treatment. 
Case 16 has also given a good functional result, 
for the patient is at the time of writing, quite symptom 
free. Actual clinical and radiological examination of 
this case during the past year, however, has not been 
possible. 
The last four cases in this group, Nos, 17, 18, 19 
and 20, were as stated above, widespread lesions with 
considerable toxaemia. In one of these (No. 19), the 
improvement has been extraordinary, and dramatic. The 
widespread lesions from which this case was suffering 
when she first came under observation, have to great extent 
disappeared leaving only slight traces of their presence. 
This patient is still improving to an extent which it is 
impossible to believe would have been obtained without 
the help of gold therapy. 
Cases 17, 18 and 20 showed absolutely no benefit 
from the treatment and the disease progressed steadily 
and without remission in spite of repeated courses of 
gold injections. All three cases ended fatally. 
The results in this group then are, one case improved, 
nine considerably improved, and four dead. 
(c) Chronic fibro -caseous cases treated with Crisalbin. 
This group comprises four cases, Nos. 21 to 21,-. 
Cases 21 and 22 both gave a comparatively short history 
of symptoms, but their lesions were such that it was obvious, 
the disease was of very old standing and that the 
symptoms complained of were in the nature of an 
exacerbation superadded to an old standing process. 
Cases 23 and 24 had had symptoms for years but these 
had been worse for a few months before coming under 
observation. 
The lesions in case 21 were mainly fibrous in 
character, and although the patient improved considerably 
under treatment, it is doubtful how much was due to the 
gold therapy, as this is the type of case which usually 
does so well under a simple sanatorium regime. 
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The same applies to cases 23 and 24, although in 
both those cases cavitation was present. The most 
outstanding feature about these three cases was the 
diminution in the quantity and bacillary content cf 
the sputum. All three were rendered sputum negative. 
In the case of No. 22, the treatment was of no 
benefit whatsoever. This case was definitely more 
advanced and of a more severe and toxic nature than the 
other three, but gold therapy did not improve his condition 
in the slightest and his progress was steadily downhill 
to a fatal termination. 
The results in this group are, therefore, three 
patients improved and one dead. 
SUMMARY OF RESULTS. 
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Effect of Gold Treatment upon the Sputum. 
One of the most noticiable effects of treatment 
was the reduction in the quantity and in bacillary content 
of the sputum. The first effect usually noticed was that 
the sputum became clearer and more mucoid in character. 
In many cases it disappeared altogether. 
Of the twenty four cases treated, twenty three had 
originally tubercle bacilli in their sputum. Of these 
twenty three, seventeen or 74A became negative, and 
have had no return of bacilli to their sputum since. 
Effect on the X -Ray Picture. 
Marked changes in the X -Ray pictures especially of 
Groups1 and 2 were seen. This was more noticeable in 
Group 2, the exudative type of cases. Here there was seen 
absorption of infiltrates and new formation of fibrous 
tissue. This latter was most noticeable in cases 10, 11 
and 12, the more nodular type. Here the new fibrous tissue 
formation was considerable and more marked than one is 
accustomed to seeing in cases not so treated. 
In the fibro -caseous group, changes in the X -Ray 
Picture were net so noticeable, as in the first two groups 
°r of such significance with regard to the ultimate prognosis. 
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Effect of Gold Treatment on the Blood. 
The work of Medlar (106), Doan and Sabin (107, 108) 
has stressed the significance of the relative numbers 
of the "three key cells" (monocytes, lymphocytes and 
neutrophiles). The position is summarised by 
Briskman (109) as follows: An increase in monocytes 
with a drop in lymphocytes, and increased "shift to the 
left" indicates an active progressive lesion. The 
lymphocytes increase with healing and decrease as the 
disease progresses; they are an indication of healing. 
The neutrophile is the essential cell in the formation 
of the uncontaminated tuberculous abscess. An early 
change following infection is the disappearance of the 
eosinophiles. When recovery is about to take place 
(1) Eosinophiles reappear; (2) the lymphocytes and 
monocytes increase and the neutrophiles decrease; 
(3) the disproportion between the "three key cells" 
returns to normal. 
In the present series, the blood changes were 
found to approximate very closely to the clinical 
condition of the patient. In conjunction with the 
clinical examination of the patient they formed a 
valuable aid in the forming of a prognosis. They 
improved pari passu with the clinical condition and 
gold treatment did not appear to exert any specific 
effect upon the blood picture. 
`'here sanocrysin rashes appeared (Cases 17 and 20) 
there was a marked eosinophilia, (20 to 303 %) This 
actually preceeded the rash in Case 17. 
In Case 15 where the rash was of a different type 
to the usual sanocrysin reaction, there was no 
eosinophilia. 
The sedimentation rate was another very useful 
aid to prognosis. All the fatal cases in this series 
had a very high initial sedimentation rate. One case, 
however, (No. 8) had an original sedimentation rate of 
48, and yet made steady progress and has given a very 
satisfactory result. The sedimentation rate in this 
case improved as the patient improved and this was 
found throughout the series. The value of the test 
appears to be not in one isolated examination, but in 
frequently repeated tests, which will show a steady 
decline in rate with genuine improvement of the 
pathological condition. Where the sedimentation curve 
appeared to differ from the rest of the clinical 
examination, it never proved to be very far wrong in 
its prognostic value. 
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TOXIC REACTIfNS. 
Very few undesirable reactions occured. Not one 
case in the series showed any signs of renal damage. 
No albuminuria was encountered and microscopical 
examination of the urine also gave consistantly negative 
results in spite of careful and repeated examinations 
at regular intervals. 
Three cases developed skin rashes. In Cases 17 and 
20 these took the form of scarlitinal rashes on trunk 
and limbs. This was accompanied in both cases by 
intense itching, malaise, a rise in temperature, and 
marked eosinophilia. In Case 17 after a rest from 
treatment, a further dose occasioned a recurrence of 
the rash and eosinophilia. Under the circumstances it 
was thought wiser to stop further injections. 
In Case 20, injections were continued after two 
weeks rest and no further reactions were encountered. 
In Case 15, the rash was entirely different from 
the usual skin reactions. It at first presented an 
appearance simulating a very acute psoriasis, and was 
associated with itching, but no general reaction or 
eosinophilia. Its subsequent course was entirely unlike 
a psoriasis, however, and although not resembling 
"Chrysiasis" the suggestion of actual deposition of 
gold in the skin could not be dismissed from the mind, 
although actual proof of this is of course not to be had. 
Two cases (18 and 23) suffered from diarrhoea and 
one of these (18) had in addition, stomatitis. 
Following a short rest from treatment these 
symptoms quickly settled down in both cases. 
Febrile reactions were encountered in one case 
only (19). This case was initially very toxic and a febrile 
reaction lasting a week and associated with general 
malaise and headache followed the third dose (0.05 gm). 
Another and shorter reaction also with general symptoms 
followed a dose of 0.1 gm. With a rest from treatment 
and a reversion to a smaller dose, it was found that 
the tolerance increased and larger doses could be given 
with no reaction. A very noticeable result of these two 
reactions in this case was a decided improvement in the 
temperature chart and general clinical condition. This 
is probably in the nature of a "shock" reaction, and must 
always be a two edged weapon, and not one which it is 
advisable to aim at, especially in a case such as this 
with widespread exudative lesions and marked toxaemia. 
The ultimate result of this case, however, has been 
spectacular in its success. 
DOSAGE. 
The doses employed in this series have been 
according to the standards of most authors, small. 
In only three cases has a dose of 0.25 gm. been 
exceeded, (Nos. 5, 18 and 20), and in these three, 
larger doses failed to influence the course of the 
disease just as had the smaller. 
It would appear from this series, therefore, 
that favourable results are obtained in suitable 
cases with small doses, and where these fail to produce 
improvement, larger doses will also fail. 
The small number of toxic reactions in this series 
appears to be an added argument in favour of small 
dosage. 
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CONCLUSIONS. 
1. Gold therapy is of definite value in the treatment 
of pulmonary tuberculosis. 
2. Its results cannot compare with those of collapse 
therapy, but it makes artificial pneumothorax possible 
in many cases of bilateral disease where otherwise it 
would be precluded by the nature and extent of the 
lesion in the contralateral lung. 
In originally unilateral disease treated by 
artificial pneumothorax it can control a new spread in 
the contralateral lung which would otherwise necessitate 
the abandonment of the collapse. 
3 In unilateral exudative disease where artificial 
pneumothorax has been tried and failed, it may so 
influence the course of the lesions as to bring about 
a condition suitable for thoracoplasty. 
It is in freshly spreading exudative or nodular lesions 
that its beneficial influence is most apparent. 
Exudative lesions undergo absorption and the productive 
nodular type fibrosis to an extent which is not usually 
seen in cases treated by sanatorium regime alone. 
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5. 
Excerbations in the course of chronic fibro- caseous 
disease may be favourably influenced. Here again it is 
the fresh spreading disease which is mainly affected. 
6. The consistence, quantity and bacillary content, of the 
sputum are all favourably influenced and in a large 
proportion of treated cases, the sputum becomes, and 
remains negative. 
7. Small doses not exceeding 0.25 gm. give just as 
favourable results as larger ones, and the undesirable 
reactions likely to result from the use of gold therapy 
are milder and much less frequent with small rather 
than with large doses. 
8. When small doses do not influence the course of the 
disease in a favourable manner it is unlikely that an 
increase in the size of the dose above 0.25 gm. will 
have any beneficial results. 
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